BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci USA. 1992;89:4845-4849. [PMID: 1317575 DOI: 10.1073/pnas.89.11.4845] [Cited by in Crossref: 534] [Cited by in F6Publishing: 511] [Article Influence: 17.8] [Reference Citation Analysis]
Number Citing Articles
1 van der Poll T, Levi M, Hack CE, ten Cate H, van Deventer SJ, Eerenberg AJ, de Groot ER, Jansen J, Gallati H, Büller HR. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 1994;179:1253-9. [PMID: 8145042 DOI: 10.1084/jem.179.4.1253] [Cited by in Crossref: 248] [Cited by in F6Publishing: 221] [Article Influence: 8.9] [Reference Citation Analysis]
2 Barrera P, Th. Boerbooms AM, Janssen EM, Sauerwein RW, Gallati H, Mulder J, Boo TD, Demacker PNM, Van De Putte LBA, Van Der Meer JWM. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor α, and interleukin-6 levels in rheumatoid arthritis. Arthritis & Rheumatism 1993;36:1070-9. [DOI: 10.1002/art.1780360807] [Cited by in Crossref: 85] [Cited by in F6Publishing: 90] [Article Influence: 2.9] [Reference Citation Analysis]
3 Rimaniol A, Boussin F, Herbelin A, De Groote D, Dormont D, Bach J, Descamps-latscha B, Zavala F. Induction of soluble tumor necrosis factor receptor (sTNF-R75) release by HIV adsorption on cultured human monocytes. Eur J Immunol 1994;24:2055-60. [DOI: 10.1002/eji.1830240918] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
4 Aparicio-Vergara M, Hommelberg PP, Schreurs M, Gruben N, Stienstra R, Shiri-Sverdlov R, Kloosterhuis NJ, de Bruin A, van de Sluis B, Koonen DP, Hofker MH. Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model. Hepatology. 2013;57:566-576. [PMID: 22941955 DOI: 10.1002/hep.26046] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
5 Khan MRI, Uwada J, Yazawa T, Islam MT, Krug SM, Fromm M, Karaki S, Suzuki Y, Kuwahara A, Yoshiki H, Sada K, Muramatsu I, Anisuzzaman ASM, Taniguchi T. Activation of muscarinic cholinoceptor ameliorates tumor necrosis factor-α-induced barrier dysfunction in intestinal epithelial cells. FEBS Letters 2015;589:3640-7. [DOI: 10.1016/j.febslet.2015.10.029] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
6 Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CWG. Interleukin-6, turnour necrosis factor and soluble turnour necrosis factor receptors in women with pre-eclampsia. BJOG:An international journal of O&G 1995;102:20-5. [DOI: 10.1111/j.1471-0528.1995.tb09020.x] [Cited by in Crossref: 292] [Cited by in F6Publishing: 279] [Article Influence: 10.8] [Reference Citation Analysis]
7 Malamitsi-puchner A, Sarandakou A, Tziotis J, Trikka P, Creatsas G. Evidence for a suppression of apoptosis in early postnatal life: Apoptosis in early postnatal life. Acta Obstetricia et Gynecologica Scandinavica 2001;80:994-7. [DOI: 10.1034/j.1600-0412.2001.801104.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
8 Kopple JD. The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure. The American Journal of Clinical Nutrition 2005;81:1257-66. [DOI: 10.1093/ajcn/81.6.1257] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 4.4] [Reference Citation Analysis]
9 Kobelt D, Zhang C, Clayton-Lucey IA, Glauben R, Voss C, Siegmund B, Stein U. Pro-inflammatory TNF-α and IFN-γ Promote Tumor Growth and Metastasis via Induction of MACC1. Front Immunol 2020;11:980. [PMID: 32670264 DOI: 10.3389/fimmu.2020.00980] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
10 Liu D, Cao G, Han L, Ye Y, Sima Y, Ge W. Flavonoids from Radix Tetrastigmae inhibit TLR4/MD-2 mediated JNK and NF-κB pathway with anti-inflammatory properties. Cytokine 2016;84:29-36. [DOI: 10.1016/j.cyto.2015.08.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
11 Gasparini C, Menegazzi R, Patriarca P, Dri P. Evidence that elastase is the TNF-R75 shedding enzyme in resting human polymorphonuclear leukocytes. FEBS Lett 2003;553:360-4. [PMID: 14572651 DOI: 10.1016/s0014-5793(03)01046-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
12 Meng X, Harken AH. The Interaction Between HSP70 and TNF-?? Expression: A Novel Mechanism for Protection of the Myocardium Against Post-Injury Depression: . Shock 2002;17:345-53. [DOI: 10.1097/00024382-200205000-00001] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 2.9] [Reference Citation Analysis]
13 Kalinkovich A, Livshits G, Engelmann H, Harpaz N, Burstein R, Kaminsky M, Wallach D, Bentwich Z. Soluble tumour necrosis factor receptors (sTNF-R) and HIV infection: correlation to CD8+ lymphocytes. Clin Exp Immunol 1993;93:350-5. [PMID: 8396513 DOI: 10.1111/j.1365-2249.1993.tb08184.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
14 Pilz G, Fraunberger P, Appel R, Kreuzer E, Werdan K, Walli A, Seidel D. Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations: . Critical Care Medicine 1996;24:596-600. [DOI: 10.1097/00003246-199604000-00008] [Cited by in Crossref: 50] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
15 Mazolewski PJ, Barber A, Williams S, Simoni J, Davis S, Shires G. Attenuating tumor necrosis factor α does not ameliorate other cytokine and peroxidase products during sepsis. The American Journal of Surgery 1999;178:556-8. [DOI: 10.1016/s0002-9610(99)00216-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Idrees S, Sridhar J, Kuriyan AE. Proliferative Vitreoretinopathy: A Review. Int Ophthalmol Clin 2019;59:221-40. [PMID: 30585928 DOI: 10.1097/IIO.0000000000000258] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
17 Bont ND, Netea MG, Rovers C, Smilde T, Hijmans A, Demacker PN, Meer JWVD, Stalenhoef AF. LPS-Induced Release of IL-1 β , IL-1Ra, IL-6, and TNF- α in Whole Blood from Patients with Familial Hypercholesterolemia: No Effect of Cholesterol-Lowering Treatment. Journal of Interferon & Cytokine Research 2006;26:101-7. [DOI: 10.1089/jir.2006.26.101] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
18 Lin E, Kotani JG, Lowry SF. Nutritional modulation of immunity and the inflammatory response. Nutrition 1998;14:545-50. [DOI: 10.1016/s0899-9007(98)00046-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
19 Speck N, Brandsch C, Schmidt N, Yazdekhasti N, Hirche F, Lucius R, Rimbach G, Stangl GI, Reiss K. The Antiatherogenic Effect of Fish Oil in Male Mice Is Associated with a Diminished Release of Endothelial ADAM17 and ADAM10 Substrates. J Nutr 2015;145:1218-26. [PMID: 25926412 DOI: 10.3945/jn.115.211375] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
20 MacKay SL, Auffenberg T, Tannahill CL, Ksontini R, Josephs MD, Nowak M, Moldawer LL, Copeland EM 3rd. Transfection of the type II TGF-beta receptor into colon cancer cells increases receptor expression, inhibits cell growth, and reduces the malignant phenotype. Ann Surg 1998;227:781-9. [PMID: 9637541 DOI: 10.1097/00000658-199806000-00001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 0.7] [Reference Citation Analysis]
21 Moldawer LL, Rogy MA, Lowry SF. The Role of Cytokines in Cancer Cachexia. JPEN J Parenter Enteral Nutr 2016;16:43S-9S. [DOI: 10.1177/014860719201600602] [Cited by in Crossref: 69] [Cited by in F6Publishing: 56] [Article Influence: 11.5] [Reference Citation Analysis]
22 Brinkley TE, Leng X, Miller ME, Kitzman DW, Pahor M, Berry MJ, Marsh AP, Kritchevsky SB, Nicklas BJ. Chronic inflammation is associated with low physical function in older adults across multiple comorbidities. J Gerontol A Biol Sci Med Sci 2009;64:455-61. [PMID: 19196644 DOI: 10.1093/gerona/gln038] [Cited by in Crossref: 172] [Cited by in F6Publishing: 173] [Article Influence: 13.2] [Reference Citation Analysis]
23 Muntané J, Montero JL, Marchal T, Perez-seoane C, Lozano JM, Fraga E, Pintado CO, Mata MDL, Miño G. Effect of PGE 1 on TNF-α status and hepatic D-galactosamine-induced apoptosis in rats. J Gastroenterol Hepatol 1998;13:197-207. [DOI: 10.1111/j.1440-1746.1998.tb00638.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.1] [Reference Citation Analysis]
24 Faulkner L, Altmann DM, Ellmerich S, Huhtaniemi I, Stamp G, Sriskandan S. Sexual Dimorphism in Superantigen Shock Involves Elevated TNF-α and TNF-α–induced Hepatic Apoptosis. Am J Respir Crit Care Med 2007;176:473-82. [DOI: 10.1164/rccm.200611-1712oc] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
25 Bell SJ, Chavali S, Baumer J, Forse RA. Resting Energy Expenditure, Caloric Intake, and Short-Term Change in HIV Infection and AIDS C. GRUNFELD, M. PANGE, L. SHIMIZU, ET AL American Journal of Clinical Nutrition 55:455-460, 1992. JPEN J Parenter Enteral Nutr 2016;17:392-4. [DOI: 10.1177/0148607193017004392] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
26 Anker SD, Coats AJ. Cardiac Cachexia. Chest 1999;115:836-47. [DOI: 10.1378/chest.115.3.836] [Cited by in Crossref: 277] [Cited by in F6Publishing: 240] [Article Influence: 12.0] [Reference Citation Analysis]
27 Dri P, Gasparini C, Menegazzi R, Cramer R, Albéri L, Presani G, Garbisa S, Patriarca P. TNF-Induced shedding of TNF receptors in human polymorphonuclear leukocytes: role of the 55-kDa TNF receptor and involvement of a membrane-bound and non-matrix metalloproteinase. J Immunol 2000;165:2165-72. [PMID: 10925303 DOI: 10.4049/jimmunol.165.4.2165] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 2.5] [Reference Citation Analysis]
28 Dai, Guzman, Bauer, Costabel. Elevated levels of soluble TNF receptors in bronchoalveolar lavage fluid in extrinsic allergic alveolitis: Soluble TNF receptors in BALF. Clinical & Experimental Allergy 1999;29:1209-13. [DOI: 10.1046/j.1365-2222.1999.00632.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
29 Di Paola R, Esposito E, Mazzon E, Genovese T, Muià C, Crisafulli C, Malleo G, Sessa E, Meli R, Cuzzocrea S. Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosan. Shock 2006;26:477-84. [PMID: 17047518 DOI: 10.1097/01.shk.0000230299.78515.2c] [Cited by in Crossref: 19] [Cited by in F6Publishing: 28] [Article Influence: 1.2] [Reference Citation Analysis]
30 Starcher B, O'neal P, Granstein RD, Beissert S. Inhibition of Neutrophil Elastase Suppresses the Development of Skin Tumors in Hairless Mice. Journal of Investigative Dermatology 1996;107:159-63. [DOI: 10.1111/1523-1747.ep12329559] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
31 Ertel W, Keel M, Bonaccio M, Steckholzer U, Gallati H, Kenney JS, Trentz O. Release of Anti-inflammatory Mediators after Mechanical Trauma Correlates with Severity of Injury and Clinical Outcome: . The Journal of Trauma: Injury, Infection, and Critical Care 1995;39:879-87. [DOI: 10.1097/00005373-199511000-00011] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 2.7] [Reference Citation Analysis]
32 Redl H, Bahrami S. Large animal models: baboons for trauma, shock, and sepsis studies. Shock 2005;24 Suppl 1:88-93. [PMID: 16374379 DOI: 10.1097/01.shk.0000191339.46777.63] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
33 Deuren M. Kinetics of tumour necrosis factor-alpha, soluble tumour necrosis factor receptors, interleukin 1-beta and its receptor antagonist during serious infections. Eur J Clin Microbiol Infect Dis 1994;13:S12-6. [DOI: 10.1007/bf02390680] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
34 van der Poll T, Lowry SF. Endogenous Mechanisms Regulating TNF and IL-1 during Sepsis. In: Vincent J, editor. Yearbook of Intensive Care and Emergency Medicine. Berlin: Springer Berlin Heidelberg; 1995. pp. 385-97. [DOI: 10.1007/978-3-642-79154-3_31] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
35 Grossman J, Chamow SM. Etanercept. In: Chamow SM, Ryll T, Lowman HB, Farson D, editors. Therapeutic Fc-Fusion Proteins. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2014. pp. 255-82. [DOI: 10.1002/9783527675272.ch10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Unnewehr H, Rittirsch D, Sarma JV, Zetoune F, Flierl MA, Perl M, Denk S, Weiss M, Schneider ME, Monk PN, Neff T, Mihlan M, Barth H, Gebhard F, Ward PA, Huber-Lang M. Changes and regulation of the C5a receptor on neutrophils during septic shock in humans. J Immunol 2013;190:4215-25. [PMID: 23479227 DOI: 10.4049/jimmunol.1200534] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 6.8] [Reference Citation Analysis]
37 Ke F, Zhang L, Liu Z, Yan S, Xu Z, Bai J, Zhu H, Lou F, Cai W, Sun Y, Gao Y, Wang H, Wang H. Soluble Tumor Necrosis Factor Receptor 1 Released by Skin-Derived Mesenchymal Stem Cells Is Critical for Inhibiting Th17 Cell Differentiation. Stem Cells Transl Med 2016;5:301-13. [PMID: 26819253 DOI: 10.5966/sctm.2015-0179] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
38 Kern WV, Oristrell J, Segura-porta F, Kern P. Release of soluble tumor necrosis factor receptors in Mediterranean spotted fever rickettsiosis. Clin Diagn Lab Immunol 1996;3:233-5. [DOI: 10.1128/cdli.3.2.233-235.1996] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
39 Keystone EC. TUMOR NECROSIS FACTOR-α BLOCKADE IN THE TREATMENT OF RHEUMATOID ARTHRITIS. Rheumatic Disease Clinics of North America 2001;27:427-43. [DOI: 10.1016/s0889-857x(05)70211-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
40 Ong KL, McClelland RL, Allison MA, Cushman M, Garg PK, Tsai MY, Rye KA, Tabet F. Lipoprotein (a) and coronary artery calcification: prospective study assessing interactions with other risk factors. Metabolism 2021;116:154706. [PMID: 33421505 DOI: 10.1016/j.metabol.2021.154706] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
41 Parissis JT, Filippatos G, Nikolaou V, Adamopoulos S. Cytokines and anti-cytokine therapeutic approaches to chronic heart failure. European Journal of Internal Medicine 2002;13:356-64. [DOI: 10.1016/s0953-6205(02)00092-4] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
42 Gentile LF, Cuenca AG, Vanzant EL, Efron PA, McKinley B, Moore F, Moldawer LL. Is there value in plasma cytokine measurements in patients with severe trauma and sepsis? Methods 2013;61:3-9. [PMID: 23669589 DOI: 10.1016/j.ymeth.2013.04.024] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
43 Zhan C, Patskovsky Y, Yan Q, Li Z, Ramagopal U, Cheng H, Brenowitz M, Hui X, Nathenson SG, Almo SC. Decoy strategies: the structure of TL1A: DcR3 complex. Structure. 2011;19:162-171. [PMID: 21300286 DOI: 10.1016/j.str.2010.12.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
44 Rowlands DJ, Islam MN, Das SR, Huertas A, Quadri SK, Horiuchi K, Inamdar N, Emin MT, Lindert J, Ten VS, Bhattacharya S, Bhattacharya J. Activation of TNFR1 ectodomain shedding by mitochondrial Ca2+ determines the severity of inflammation in mouse lung microvessels. J Clin Invest 2011;121:1986-99. [PMID: 21519143 DOI: 10.1172/JCI43839] [Cited by in Crossref: 71] [Cited by in F6Publishing: 47] [Article Influence: 6.5] [Reference Citation Analysis]
45 Lien E, Liabakk N, Johnsen A, Nonstad U, Sundan A, Espevik T. Polymorphonuclear granulocytes enhance lipopolysaccharide-induced soluble p75 tumor necrosis factor receptor release from mononuclear cells. Eur J Immunol 1995;25:2714-7. [DOI: 10.1002/eji.1830250948] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
46 Cao YZ, Tu YY, Chen X, Wang BL, Zhong YX, Liu MH. Protective effect of Ulinastatin against murine models of sepsis: inhibition of TNF-α and IL-6 and augmentation of IL-10 and IL-13. Exp Toxicol Pathol. 2012;64:543-547. [PMID: 21159497 DOI: 10.1016/j.etp.2010.11.011] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 4.5] [Reference Citation Analysis]
47 Gibot S, Kolopp-Sarda MN, Béné MC, Bollaert PE, Lozniewski A, Mory F, Levy B, Faure GC. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med. 2004;200:1419-1426. [PMID: 15557347 DOI: 10.1084/jem.20040708] [Cited by in Crossref: 251] [Cited by in F6Publishing: 253] [Article Influence: 13.9] [Reference Citation Analysis]
48 Gupta A, Watson DI. Effect of laparoscopy on immune function. Br J Surg. 2001;88:1296-1306. [PMID: 11578282 DOI: 10.1046/j.0007-1323.2001.01860.x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 92] [Article Influence: 5.2] [Reference Citation Analysis]
49 Garrison L, McDonnell ND. Etanercept: therapeutic use in patients with rheumatoid arthritis. Ann Rheum Dis 1999;58 Suppl 1:I65-9. [PMID: 10577976 DOI: 10.1136/ard.58.2008.i65] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 2.0] [Reference Citation Analysis]
50 Miele L, Forgione A, Gasbarrini G, Grieco A. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Transl Res. 2007;149:114-125. [PMID: 17320797 DOI: 10.1016/j.trsl.2006.11.011] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
51 Gabriel CM, Gregson NA, Wood NW, Hughes RA. Immunological study of hereditary motor and sensory neuropathy type 1a (HMSN1a). J Neurol Neurosurg Psychiatry 2002;72:230-5. [PMID: 11796774 DOI: 10.1136/jnnp.72.2.230] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
52 van der Houwen T, van Laar J. Behҫet's Disease, and the Role of TNF-α and TNF-α Blockers. Int J Mol Sci 2020;21:E3072. [PMID: 32349254 DOI: 10.3390/ijms21093072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Cavaillon J, Adib-conquy M. The Pro-Inflammatory Cytokine Cascade. In: Marshall JC, Cohen J, editors. Immune Response in the Critically Ill. Berlin: Springer Berlin Heidelberg; 2000. pp. 37-66. [DOI: 10.1007/978-3-642-57210-4_4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
54 Granell S, Pereda J, Gómez-Cambronero L, Cassinello N, Sabater L, Closa D, Sastre J. Circulating TNF-alpha and its soluble receptors during experimental acute pancreatitis. Cytokine. 2004;25:187-191. [PMID: 15164724 DOI: 10.1016/j.cyto.2003.10.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
55 Allen SJ, Mcbride WT, Mcmurray TJ, Phillips AS, Penugonda SP, Campalani G, Young IS, Armstrong MA. Cell Salvage Alters the Systemic Inflammatory Response After Off-Pump Coronary Artery Bypass Grafting Surgery. The Annals of Thoracic Surgery 2007;83:578-85. [DOI: 10.1016/j.athoracsur.2006.09.041] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
56 Stojanović D, Bůžková P, Mukamal KJ, Heckbert SR, Psaty BM, Fink HA, Cauley JA, Wallace E, Curtis LH, Hirsch C, Budoff M, Li D, Young R, Jalal D, Delaney JA. Soluble Inflammatory Markers and Risk of Incident Fractures in Older Adults: The Cardiovascular Health Study. J Bone Miner Res 2018;33:221-8. [PMID: 28976598 DOI: 10.1002/jbmr.3301] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
57 Veroni C, Gabriele L, Canini I, Castiello L, Coccia E, Remoli ME, Columba-Cabezas S, Aricò E, Aloisi F, Agresti C. Activation of TNF receptor 2 in microglia promotes induction of anti-inflammatory pathways. Mol Cell Neurosci 2010;45:234-44. [PMID: 20600925 DOI: 10.1016/j.mcn.2010.06.014] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 5.4] [Reference Citation Analysis]
58 Finck BN, Johnson RW. Tumor necrosis factor-? regulates secretion of the adipocyte-derived cytokine, leptin. Microsc Res Tech 2000;50:209-15. [DOI: 10.1002/1097-0029(20000801)50:3<209::aid-jemt4>3.0.co;2-t] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
59 Liu D, Wei W, Song L. Upregulation of TNF-alpha and IL-6 mRNA in mouse liver induced by bacille Calmette-Guerin plus lipopolysaccharide. Acta Pharmacologica Sinica 2006;27:460-8. [DOI: 10.1111/j.1745-7254.2006.00301.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
60 Tu TH, Kim C, Kang J, Nam-goong IS, Nam CW, Kim ES, Kim YI, Choi JI, Kawada T, Goto T, Park T, Yoon Park JH, Choi M, Yu R. Levels of 4-1BB transcripts and soluble 4-1BB protein are elevated in the adipose tissue of human obese subjects and are associated with inflammatory and metabolic parameters. Int J Obes 2014;38:1075-82. [DOI: 10.1038/ijo.2013.222] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
61 Al-Lamki RS, Mayadas TN. TNF receptors: signaling pathways and contribution to renal dysfunction. Kidney Int 2015;87:281-96. [PMID: 25140911 DOI: 10.1038/ki.2014.285] [Cited by in Crossref: 79] [Cited by in F6Publishing: 75] [Article Influence: 9.9] [Reference Citation Analysis]
62 Ding M, Si D, Zhang W, Feng Z, He M, Yang P. Red yeast rice repairs kidney damage and reduces inflammatory transcription factors in rat models of hyperlipidemia. Exp Ther Med 2014;8:1737-44. [PMID: 25371725 DOI: 10.3892/etm.2014.2035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
63 Gould DW, Lahart I, Carmichael AR, Koutedakis Y, Metsios GS. Cancer cachexia prevention via physical exercise: molecular mechanisms. J Cachexia Sarcopenia Muscle 2013;4:111-24. [PMID: 23239116 DOI: 10.1007/s13539-012-0096-0] [Cited by in Crossref: 107] [Cited by in F6Publishing: 95] [Article Influence: 10.7] [Reference Citation Analysis]
64 Davidsen SK, Summers JB. Review Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Inhibitors of TNFα synthesis. Expert Opinion on Therapeutic Patents 2008;5:1087-100. [DOI: 10.1517/13543776.5.10.1087] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
65 Vary TC, Deiter G, Kimball SR. Phosphorylation of eukaryotic initiation factor eIF2Bε in skeletal muscle during sepsis. American Journal of Physiology-Endocrinology and Metabolism 2002;283:E1032-9. [DOI: 10.1152/ajpendo.00171.2002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
66 Waetzig GH, Rosenstiel P, Arlt A, Till A, Bräutigam K, Schäfer H, Rose-John S, Seegert D, Schreiber S. Soluble tumor necrosis factor (TNF) receptor-1 induces apoptosis via reverse TNF signaling and autocrine transforming growth factor-beta1. FASEB J 2005;19:91-3. [PMID: 15514103 DOI: 10.1096/fj.04-2073fje] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 3.9] [Reference Citation Analysis]
67 Fitzgerald KA, O'neill LA, Gearing AJ, Callard RE. The cytokine network. The Cytokine FactsBook and Webfacts. Elsevier; 2001. pp. 13-20. [DOI: 10.1016/b978-012155142-1/50004-x] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
68 Schönbohn H, Schuler M, Kolbe K, Peschel C, Huber C, Bemb W, Aulitzky WE. Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: Results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia. Ann Hematol 1995;71:161-8. [DOI: 10.1007/bf01910312] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
69 Ng SSW, Zhang H, Wang L, Citrin D, Dawson LA. Association of pro-inflammatory soluble cytokine receptors early during hepatocellular carcinoma stereotactic radiotherapy with liver toxicity. NPJ Precis Oncol 2020;4:17. [PMID: 32695883 DOI: 10.1038/s41698-020-0124-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
70 Kato A, Takita T, Furuhashi M, Takahashi T, Watanabe T, Maruyama Y, Hishida A. Polymethylmethacrylate efficacy in reduction of renal itching in hemodialysis patients: crossover study and role of tumor necrosis factor-alpha. Artif Organs 2001;25:441-7. [PMID: 11453873 DOI: 10.1046/j.1525-1594.2001.025006441.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
71 Roggero E, Perez A, Tamae-Kakazu M, Piazzon I, Nepomnaschy I, Wietzerbin J, Serra E, Revelli S, Bottasso O. Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities. Clin Exp Immunol 2002;128:421-8. [PMID: 12067296 DOI: 10.1046/j.1365-2249.2002.01874.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 4.1] [Reference Citation Analysis]
72 Kaplanski G, Marin V, Maisonobe T, Sbai A, Farnarier C, Ghillani P, Thirion X, Durand JM, Harlé JR, Bongrand P, Piette JC, Cacoub P. Increased soluble p55 and p75 tumour necrosis factor-alpha receptors in patients with hepatitis C-associated mixed cryoglobulinaemia. Clin Exp Immunol 2002;127:123-30. [PMID: 11882042 DOI: 10.1046/j.1365-2249.2002.01728.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
73 Steinhoff M, Luger T. The Skin Cytokine Network. In: Bos J, editor. Skin Immune System. CRC Press; 2004. pp. 349-72. [DOI: 10.1201/b14248-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
74 Smith S, Skerrett SJ, Chi EY, Jonas M, Mohler K, Wilson CB. The locus of tumor necrosis factor-alpha action in lung inflammation. Am J Respir Cell Mol Biol 1998;19:881-91. [PMID: 9843922 DOI: 10.1165/ajrcmb.19.6.3146] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
75 Barger SW. Tumor Necrosis Factor. In: Mattson MP, editor. Neuroprotective Signal Transduction. Totowa: Humana Press; 1998. pp. 163-83. [DOI: 10.1007/978-1-59259-475-7_9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
76 Mohamed-Ali V, Goodrick S, Bulmer K, Holly JM, Yudkin JS, Coppack SW. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 1999;277:E971-5. [PMID: 10600783 DOI: 10.1152/ajpendo.1999.277.6.E971] [Cited by in Crossref: 56] [Cited by in F6Publishing: 82] [Article Influence: 2.5] [Reference Citation Analysis]
77 Lisman KA, Stetson SJ, Koerner MM, Farmer JA, Torre-Amione G. The role of tumor necrosis factor alpha blockade in the treatment of congestive heart failure. Congest Heart Fail 2002;8:275-9. [PMID: 12368591 DOI: 10.1111/j.1527-5299.2002.01155.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
78 Oberholzer A, Oberholzer C, Moldawer LL. Cytokine signaling-regulation of the immune response in normal and critically ill states: . Critical Care Medicine 2000;28:N3-N12. [DOI: 10.1097/00003246-200004001-00002] [Cited by in Crossref: 156] [Cited by in F6Publishing: 142] [Article Influence: 7.1] [Reference Citation Analysis]
79 Hua Y, Shen M, McDonald C, Yao Q. Autophagy dysfunction in autoinflammatory diseases. J Autoimmun 2018;88:11-20. [PMID: 29108670 DOI: 10.1016/j.jaut.2017.10.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
80 Abu El-Asrar AM, Berghmans N, Al-Obeidan SA, Gikandi PW, Opdenakker G, Van Damme J, Struyf S. Soluble cytokine receptor levels in aqueous humour of patients with specific autoimmune uveitic entities: sCD30 is a biomarker of granulomatous uveitis. Eye (Lond) 2020;34:1614-23. [PMID: 31804623 DOI: 10.1038/s41433-019-0693-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
81 Hensler T, Sauerland S, Bouillon B, Raum M, Rixen D, Helling HJ, Andermahr J, Neugebauer EA. Association between injury pattern of patients with multiple injuries and circulating levels of soluble tumor necrosis factor receptors, interleukin-6 and interleukin-10, and polymorphonuclear neutrophil elastase. J Trauma 2002;52:962-70. [PMID: 11988666 DOI: 10.1097/00005373-200205000-00023] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 2.0] [Reference Citation Analysis]
82 Messer J, Eyer D, Donato L, Gallati H, Matis J, Simeoni U. Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection. The Journal of Pediatrics 1996;129:574-80. [DOI: 10.1016/s0022-3476(96)70123-3] [Cited by in Crossref: 113] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
83 Sancho Ferrando E, Hanslin K, Hultström M, Larsson A, Frithiof R, Lipcsey M; Uppsala Intensive Care COVID-19 Research Group. Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID-19 patients: A prospective observational study. Cytokine 2022;149:155727. [PMID: 34628127 DOI: 10.1016/j.cyto.2021.155727] [Reference Citation Analysis]
84 Keel M, Ecknauer E, Stocker R, Ungethum U, Steckholzer U, Kenney J, Gallati H, Trentz O, Ertel W. Different Pattern of Local and Systemic Release of Proinflammatory and Anti-inflammatory Mediators in Severely Injured Patients with Chest Trauma: . The Journal of Trauma: Injury, Infection, and Critical Care 1996;40:907-14. [DOI: 10.1097/00005373-199606000-00008] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 2.6] [Reference Citation Analysis]
85 Hanck C, Rossol S, Hartmann A, Singer MV. Cytokine gene expression in peripheral blood mononuclear cells reflects a systemic immune response in alcoholic chronic pancreatitis. Int J Pancreatol. 1999;26:137-145. [PMID: 10732290 DOI: 10.1385/IJGC:26:3:137] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
86 Fabris C, Del Forno M, Falleti E, Toniutto P, Pirisi M. Kinetics of serum soluble tumour necrosis factor receptor (TNF-R) type-I and type-II after a single interferon-alpha (IFN-alpha) injection in chronic hepatitis C. Clin Exp Immunol. 1999;117:556-560. [PMID: 10469062 DOI: 10.1046/j.1365-2249.1999.00992.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
87 Jin H, Yang R, Marsters S, Ashkenazi A, Bunting S, Marra MN, Scott RW, Baker JB. Protection against endotoxic shock by bactericidal/permeability-increasing protein in rats. J Clin Invest 1995;95:1947-52. [PMID: 7706502 DOI: 10.1172/JCI117877] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
88 Wang H, Wei W, Shen YX, Dong C, Zhang LL, Wang NP, Yue L, Xu SY. Protective effect of melatonin against liver injury in mice induced by Bacillus Calmette-Guerin plus lipopolysaccharide. World J Gastroenterol 2004; 10(18): 2690-2696 [PMID: 15309720 DOI: 10.3748/wjg.v10.i18.2690] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
89 Neuner P, Pourmojib M, Klosner G, Trautinger F, Knobler R. Increased release of the tumour necrosis factor receptor p75 by immortalized human keratinocytes results from an activated shedding mechanism and is not related to augmented steady-state levels of p75 mRNA. Arch Dermatol Res 1996;288:691-6. [DOI: 10.1007/bf02505279] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
90 van der Poll T, Levi M, ten Cate H, Jansen J, Biemond BJ, Haagmans BL, Eerenberg A, van Deventer SJ, Hack CE, ten Cate JW. Effect of postponed treatment with an anti-tumour necrosis factor (TNF) F(ab')2 fragment on endotoxin-induced cytokine and neutrophil responses in chimpanzees. Clin Exp Immunol 1995;100:21-5. [PMID: 7697917 DOI: 10.1111/j.1365-2249.1995.tb03598.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
91 Cai M, Bonella F, Dai H, Sarria R, Guzman J, Costabel U. Macrolides inhibit cytokine production by alveolar macrophages in bronchiolitis obliterans organizing pneumonia. Immunobiology 2013;218:930-7. [DOI: 10.1016/j.imbio.2012.10.014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
92 Hoyos S, Granell S, Heredia N, Bulbena O, Closa D, Fernández-Cruz L. Influence of portal blood on the development of systemic inflammation associated with experimental acute pancreatitis. Surgery 2005;137:186-91. [PMID: 15674200 DOI: 10.1016/j.surg.2004.06.039] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
93 Moshage H. Cytokines and the hepatic acute phase response. J Pathol 1997;181:257-66. [PMID: 9155709 DOI: 10.1002/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U] [Cited by in Crossref: 429] [Cited by in F6Publishing: 140] [Article Influence: 17.2] [Reference Citation Analysis]
94 Dai H, Guzman J, Chen B, Costabel U. Production of Soluble Tumor Necrosis Factor Receptors and Tumor Necrosis Factor-α by Alveolar Macrophages in Sarcoidosis and Extrinsic Allergic Alveolitis. Chest 2005;127:251-6. [DOI: 10.1378/chest.127.1.251] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 2.5] [Reference Citation Analysis]
95 Freeman LM, Roubenoff R. The Nutrition Implications of Cardiac Cachexia. Nutrition Reviews 1994;52:340-7. [DOI: 10.1111/j.1753-4887.1994.tb01358.x] [Cited by in Crossref: 104] [Cited by in F6Publishing: 88] [Article Influence: 8.0] [Reference Citation Analysis]
96 Selinsky CL, Howell MD. Soluble tumor necrosis factor receptor type I enhances tumor development and persistence in vivo. Cell Immunol 2000;200:81-7. [PMID: 10753499 DOI: 10.1006/cimm.2000.1622] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
97 Barbour KE, Boudreau R, Danielson ME, Youk AO, Wactawski-Wende J, Greep NC, LaCroix AZ, Jackson RD, Wallace RB, Bauer DC, Allison MA, Cauley JA. Inflammatory markers and the risk of hip fracture: the Women's Health Initiative. J Bone Miner Res 2012;27:1167-76. [PMID: 22392817 DOI: 10.1002/jbmr.1559] [Cited by in Crossref: 76] [Cited by in F6Publishing: 66] [Article Influence: 7.6] [Reference Citation Analysis]
98 Goggs R, Letendre JA. High Mobility Group Box-1 and Pro-inflammatory Cytokines Are Increased in Dogs After Trauma but Do Not Predict Survival. Front Vet Sci 2018;5:179. [PMID: 30105229 DOI: 10.3389/fvets.2018.00179] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
99 Duncombe G, Veldhuizen RA, Gratton RJ, Han VK, Richardson BS. IL-6 and TNFalpha across the umbilical circulation in term pregnancies: relationship with labour events. Early Hum Dev 2010;86:113-7. [PMID: 20171025 DOI: 10.1016/j.earlhumdev.2010.01.027] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
100 Weiss M, Martignoni M, Petropoulou T, Sölder B, Belohradsky BH. Increased serum levels of soluble tumor necrosis factor receptors (sTNF-Rs) in children and adolescents with vertically and horizontally transmitted HIV infection. Infection 1996;24:301-8. [PMID: 8875282 DOI: 10.1007/BF01743365] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
101 Koh Y, Hybertson BM, Jepson EK, Repine JE. Tumor necrosis factor induced acute lung leak in rats: less than with interleukin-1. Inflammation. 1996;20:461-469. [PMID: 8894711 DOI: 10.1007/BF0148703] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
102 Endo Y, Shibazaki M, Yamaguchi K, Kai K, Sugawara S, Takada H, Kikuchi H, Kumagai K. Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment. Br J Pharmacol. 1999;128:5-12. [PMID: 10498828 DOI: 10.1038/sj.bjp.0702747] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 1.8] [Reference Citation Analysis]
103 Wang C, Yu X, Yan Y, Yang W, Zhang S, Xiang Y, Zhang J, Wang W. Tumor necrosis factor-α: a key contributor to intervertebral disc degeneration. Acta Biochim Biophys Sin 2016;49:1-13. [DOI: 10.1093/abbs/gmw112] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 8.3] [Reference Citation Analysis]
104 Juffermans NP, Verbon A, van Deventer SJ, van Deutekom H, Speelman P, van der Poll T. Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis. Am J Respir Crit Care Med 1998;157:1328-31. [PMID: 9563758 DOI: 10.1164/ajrccm.157.4.9709126] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 2.2] [Reference Citation Analysis]
105 Rogy MA, Oldenburg HSA, Calvano SE, Montegut WJ, Stackpole SA, van Zee KJ, Marra MN, Scott RW, Seilhammer JJ, Moldawer LL, Lowry SF. The role of bactericidal/permeability-increasing protein in the treatment of primate bacteremia and septic shock. J Clin Immunol 1994;14:120-33. [DOI: 10.1007/bf01541345] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
106 Dickensheets HL, Freeman SL, Smith MF, Donnelly RP. Interleukin-10 Upregulates Tumor Necrosis Factor Receptor Type-II (p75) Gene Expression in Endotoxin-Stimulated Human Monocytes. Blood 1997;90:4162-71. [DOI: 10.1182/blood.v90.10.4162] [Cited by in Crossref: 61] [Article Influence: 2.4] [Reference Citation Analysis]
107 Jansen J, van der Poll T, Levi M, ten Cate H, Gallati H, ten Cate JW, van Deventer SJH. Inhibition of the release of soluble tumor necrosis factor receptors in experimental endotoxemia by an anti-tumor necrosis factor-α antibody. J Clin Immunol 1995;15:45-50. [DOI: 10.1007/bf01489489] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
108 Kamihira S, Yamada Y, Maeda T. Clinical and oncological significance of aberrant Fas (APO-1/CD95) isoform expression in adult T-cell leukemia. Indian J Clin Biochem 2000;15:101-9. [PMID: 23105273 DOI: 10.1007/BF02867549] [Reference Citation Analysis]
109 Mausner-Fainberg K, Regev K, Kolb H, Vaknin-Dembinsky A, Karni A. Increased neutralization capacity of TNF-α in sera of relapsing remitting multiple sclerosis patients is not related to soluble TNF-α receptors or anti-TNF-α autoantibody levels. J Neuroimmunol 2015;286:83-5. [PMID: 26298329 DOI: 10.1016/j.jneuroim.2015.07.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
110 Lukacs NW, Ward PA. Inflammatory Mediators, Cytokines, and Adhesion Molecules in Pulmonary Inflammation and Injury. Advances in Immunology Volume 62. Elsevier; 1996. pp. 257-304. [DOI: 10.1016/s0065-2776(08)60432-0] [Cited by in Crossref: 74] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
111 Gough P, Myles IA. Tumor Necrosis Factor Receptors: Pleiotropic Signaling Complexes and Their Differential Effects. Front Immunol 2020;11:585880. [PMID: 33324405 DOI: 10.3389/fimmu.2020.585880] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
112 Maymon E, Ghezzi F, Edwin SS, Mazor M, Yoon BH, Gomez R, Romero R. The tumor necrosis factor α and its soluble receptor profile in term and preterm parturition. American Journal of Obstetrics and Gynecology 1999;181:1142-8. [DOI: 10.1016/s0002-9378(99)70097-9] [Cited by in Crossref: 99] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
113 Dellinger RP. Tumor necrosis factor in septic shock and multiple system trauma. Crit Care Med 1997;25:1771-3. [PMID: 9366750 DOI: 10.1097/00003246-199711000-00005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
114 Huang Z, Chiang B, Hsu K. Serum Level of Soluble Tumor Necrosis Factor Receptor II (sTNF-R75) Is Apparently an Index of Overall Monocyte-Related Infectious and Inflammatory Activity. The American Journal of the Medical Sciences 2000;320:183-7. [DOI: 10.1016/s0002-9629(15)40816-x] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
115 Millar JS, Ky B, Wolfe ML, Pruscino L, Baer A, Rader DJ. Short-term treatment with high-dose atorvastatin reduces LDL cholesterol but shows no anti-inflammatory effects in normolipidemic subjects with normal CRP levels. Clin Transl Sci 2010;3:140-6. [PMID: 20718814 DOI: 10.1111/j.1752-8062.2010.00211.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
116 Moura AS, Carmo RA, Teixeira AL, Leite VH, Rocha MO. Soluble inflammatory markers as predictors of liver histological changes in patients with chronic hepatitis C virus infection. Eur J Clin Microbiol Infect Dis. 2010;29:1153-1161. [PMID: 20559676 DOI: 10.1007/s10096-010-0981-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
117 Lodato RF, Khan AR, Zembowicz MJ, Weisbrodt NW, Pressley TA, Li Y, Lodato JA, Zembowicz A, Moody FG. Roles of IL-1 and TNF in the decreased ileal muscle contractility induced by lipopolysaccharide. American Journal of Physiology-Gastrointestinal and Liver Physiology 1999;276:G1356-62. [DOI: 10.1152/ajpgi.1999.276.6.g1356] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
118 Wakelkamp IM, Gerding MN, Van Der Meer JW, Prummel MF, Wiersinga WM. Both Th1- and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy. Clin Exp Immunol 2000;121:453-7. [PMID: 10971510 DOI: 10.1046/j.1365-2249.2000.01335.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 2.5] [Reference Citation Analysis]
119 Choi SJ, Lee KH, Park HS, Kim SK, Koh CM, Park JY. Differential expression, shedding, cytokine regulation and function of TNFR1 and TNFR2 in human fetal astrocytes. Yonsei Med J 2005;46:818-26. [PMID: 16385659 DOI: 10.3349/ymj.2005.46.6.818] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
120 Scuric Z, Carroll JE, Bower JE, Ramos-Perlberg S, Petersen L, Esquivel S, Hogan M, Chapman AM, Irwin MR, Breen EC, Ganz PA, Schiestl R. Biomarkers of aging associated with past treatments in breast cancer survivors. NPJ Breast Cancer 2017;3:50. [PMID: 29238750 DOI: 10.1038/s41523-017-0050-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
121 Wufuer M, Lee G, Hur W, Jeon B, Kim BJ, Choi TH, Lee S. Skin-on-a-chip model simulating inflammation, edema and drug-based treatment. Sci Rep 2016;6:37471. [PMID: 27869150 DOI: 10.1038/srep37471] [Cited by in Crossref: 125] [Cited by in F6Publishing: 108] [Article Influence: 20.8] [Reference Citation Analysis]
122 Morais BS, Teixeira AL, Maciel JF, Lima AA, Barbosa IG, Sanches MD. Soluble tumor necrosis factor receptors as predictors of 1-year mortality and renal dysfunction after liver transplantation. Transpl Immunol 2016;35:29-33. [PMID: 26845019 DOI: 10.1016/j.trim.2016.01.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
123 Liu Z, Lerman LO, Tang H, Barber C, Wan L, Hui MM, Furenlid LR, Woolfenden JM. Inflammation imaging of atherosclerosis in Apo-E-deficient mice using a (99m)Tc-labeled dual-domain cytokine ligand. Nucl Med Biol 2014;41:785-92. [PMID: 25195016 DOI: 10.1016/j.nucmedbio.2014.08.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
124 Casey LC. Immunologic response to infection and its role in septic shock. Crit Care Clin 2000;16:193-213. [PMID: 10768079 DOI: 10.1016/s0749-0704(05)70107-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
125 Doody A, Jackson S, Elliott JA, Canavan RJ, Godson C, Slattery D, Twomey PJ, Mckenna MJ, le Roux CW, Docherty NG. Validating the association between plasma tumour necrosis factor receptor 1 levels and the presence of renal injury and functional decline in patients with Type 2 diabetes. Journal of Diabetes and its Complications 2018;32:95-9. [DOI: 10.1016/j.jdiacomp.2017.09.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
126 Ashare A, Powers LS, Butler NS, Doerschug KC, Monick MM, Hunninghake GW. Anti-inflammatory response is associated with mortality and severity of infection in sepsis. Am J Physiol Lung Cell Mol Physiol 2005;288:L633-40. [PMID: 15579629 DOI: 10.1152/ajplung.00231.2004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 55] [Article Influence: 3.7] [Reference Citation Analysis]
127 Wilson S, Jones FM, Mwatha JK, Kimani G, Booth M, Kariuki HC, Vennervald BJ, Ouma JH, Muchiri E, Dunne DW. Hepatosplenomegaly associated with chronic malaria exposure: evidence for a pro-inflammatory mechanism exacerbated by schistosomiasis. Parasite Immunol 2009;31:64-71. [PMID: 19149774 DOI: 10.1111/j.1365-3024.2008.01078.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
128 Corvino CL, Mamoni RL, Fagundes GZ, Blotta MH. Serum interleukin-18 and soluble tumour necrosis factor receptor 2 are associated with disease severity in patients with paracoccidioidomycosis. Clin Exp Immunol 2007;147:483-90. [PMID: 17302897 DOI: 10.1111/j.1365-2249.2006.03308.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
129 Armstrong L, Godinho SI, Uppington KM, Whittington HA, Millar AB. Contribution of TNF-alpha converting enzyme and proteinase-3 to TNF-alpha processing in human alveolar macrophages. Am J Respir Cell Mol Biol 2006;34:219-25. [PMID: 16210695 DOI: 10.1165/rcmb.2005-0087OC] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
130 Welborn MB, Oldenburg HSA, Hess PJ, Huber TS, Martin TD, Rauwerda JA, Wesdorp RIC, Espat NJ, Copeland EM, Moldawer LL, Seeger JM. The relationship between visceral ischemia, proinflammatory cytokines, and organ injury in patients undergoing thoracoabdominal aortic aneurysm repair: . Critical Care Medicine 2000;28:3191-7. [DOI: 10.1097/00003246-200009000-00013] [Cited by in Crossref: 92] [Cited by in F6Publishing: 78] [Article Influence: 4.2] [Reference Citation Analysis]
131 Douvdevani A, Einbinder T, Yulzari R, Rogachov B, Chaimovitz C. TNF-receptors on human peritoneal mesothelial cells: Regulation of receptor levels and shedding by IL-1α and TNFα. Kidney International 1996;50:219-28. [DOI: 10.1038/ki.1996.305] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
132 Masson CJ, Mensink RP. Exchanging saturated fatty acids for (n-6) polyunsaturated fatty acids in a mixed meal may decrease postprandial lipemia and markers of inflammation and endothelial activity in overweight men. J Nutr 2011;141:816-21. [PMID: 21430255 DOI: 10.3945/jn.110.136432] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 4.9] [Reference Citation Analysis]
133 Braga EL, Moura P, Pinto LM, Ignácio SR, Oliveira MJ, Cordeiro MT, Kubelka CF. Detection of circulant tumor necrosis factor-alpha, soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with dengue fever and dengue hemorrhagic fever. Mem Inst Oswaldo Cruz 2001;96:229-32. [PMID: 11285501 DOI: 10.1590/s0074-02762001000200015] [Cited by in Crossref: 68] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
134 Natarajan S, Kim J, Remick DG. Acute pulmonary lipopolysaccharide tolerance decreases TNF-alpha without reducing neutrophil recruitment. J Immunol 2008;181:8402-8. [PMID: 19050257 DOI: 10.4049/jimmunol.181.12.8402] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
135 Eason JD, Pascual M, Wee S, Farrell M, Phelan J, Boskovic S, Blosch C, Mohler KM, Cosimi AB. EVALUATION OF RECOMBINANT HUMAN SOLUBLE DIMERIC TUMOR NECROSIS FACTOR RECEPTOR FOR PREVENTION OF OKT3-ASSOCIATED ACUTE CLINICAL SYNDROME1,2: . Transplantation 1996;61:224-8. [DOI: 10.1097/00007890-199601270-00011] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 1.3] [Reference Citation Analysis]
136 Meng X, Ao L, Meldrum DR, Cain BS, Shames BD, Selzman CH, Banerjee A, Harken AH. TNF-alpha and myocardial depression in endotoxemic rats: temporal discordance of an obligatory relationship. Am J Physiol 1998;275:R502-8. [PMID: 9688686 DOI: 10.1152/ajpregu.1998.275.2.R502] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
137 Aukrust P, Ueland T, Lien E, Bendtzen K, Müller F, Andreassen AK, Nordøy I, Aass H, Espevik T, Simonsen S, Frøland SS, Gullestad L. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. The American Journal of Cardiology 1999;83:376-82. [DOI: 10.1016/s0002-9149(98)00872-8] [Cited by in Crossref: 333] [Cited by in F6Publishing: 85] [Article Influence: 14.5] [Reference Citation Analysis]
138 Gibot S, Kolopp-Sarda MN, Béné MC, Bollaert PE, Lozniewski A, Mory F, Levy B, Faure GC. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med. 2004;200:1419-1426. [PMID: 15557347 DOI: 10.1084/jem.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
139 Aukrust P, Liabakk NB, Müller F, Espevik T, Frøland SS. Activation of tumor necrosis factor--alpha system in HIV-1 infection: association with markers of immune activation. Infection 1995;23:9-15. [PMID: 7744500 DOI: 10.1007/BF01710050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
140 Jin L, Raymond DP, Crabtree TD, Pelletier SJ, Houlgrave CW, Pruett TL, Sawyer RG. Enhanced murine macrophage TNF receptor shedding by cytosine-guanine sequences in oligodeoxynucleotides. J Immunol 2000;165:5153-60. [PMID: 11046047 DOI: 10.4049/jimmunol.165.9.5153] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
141 Secher T, Vasseur V, Poisson DM, Mitchell JA, Cunha FQ, Alves-Filho JC, Ryffel B. Crucial role of TNF receptors 1 and 2 in the control of polymicrobial sepsis. J Immunol 2009;182:7855-64. [PMID: 19494310 DOI: 10.4049/jimmunol.0804008] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
142 Kato M, Hattori T, Kato Y, Matsumoto Y, Yamashita T, Nakashima I. Elevated soluble tumor necrosis factor receptor levels in seasonal allergic rhinitis patients. Allergy 1999;54:278-82. [PMID: 10321565 DOI: 10.1034/j.1398-9995.1999.00942.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
143 Hise ME, Compher C, Harlan L, Kohlmeier JE, Benedict SH, Gajewski B, Brown JC. Inflammatory mediators and immune function are altered in home parenteral nutrition patients. Nutrition 2006;22:97-103. [DOI: 10.1016/j.nut.2005.05.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
144 Wiebe S, Hafezi M, Sandhu H, Sims S, Dixon S. Osteoclast activation in inflammatory periodontal diseases. Oral Diseases 1996;2:167-80. [DOI: 10.1111/j.1601-0825.1996.tb00218.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
145 Oral H, Kapadia S, Nakano M, Torre-Amione G, Lee J, Lee-Jackson D, Young JB, Mann DL. Tumor necrosis factor-alpha and the failing human heart. Clin Cardiol 1995;18:IV20-7. [PMID: 7489617 DOI: 10.1002/clc.4960181605] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 1.6] [Reference Citation Analysis]
146 Ferran C, Dautry F, Mérite S, Sheehan K, Schreiber R, Grau G, Bach JF, Chatenoud L. Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo. J Clin Invest 1994;93:2189-96. [PMID: 8182150 DOI: 10.1172/JCI117215] [Cited by in Crossref: 63] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
147 Malejczyk M, Jóźwiak J, Osiecka A, Roszkowski PI, Mazurkiewicz-Smoktunowicz W, Rogoziński TT, Walczak L, Jabłońska S, Majewski S, Malejczyk J. Serum levels of soluble tumor-necrosis-factor receptors in patients with benign and malignant HPV-associated anogenital lesions. Int J Cancer 1997;73:16-9. [PMID: 9334803 DOI: 10.1002/(sici)1097-0215(19970926)73:1<16::aid-ijc3>3.0.co;2-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
148 Landek-Salgado MA, Rose NR, Caturegli P. Placenta suppresses experimental autoimmune hypophysitis through soluble TNF receptor 1. J Autoimmun 2012;38:J88-96. [PMID: 21788115 DOI: 10.1016/j.jaut.2011.07.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
149 Mohamed-Ali V, Armstrong L, Clarke D, Bolton CH, Pinkney JH. Evidence for the regulation of levels of plasma adhesion molecules by proinflammatory cytokines and their soluble receptors in type 1 diabetes. J Intern Med 2001;250:415-21. [PMID: 11887976 DOI: 10.1046/j.1365-2796.2001.00900.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.1] [Reference Citation Analysis]
150 Lee E, Kehrli ME, Taylor MJ. Cloning and sequencing of cDNA encoding bovine tumor necrosis factor (TNF)-receptor I. Veterinary Immunology and Immunopathology 1998;61:379-85. [DOI: 10.1016/s0165-2427(97)00136-0] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
151 Selinsky CL, Boroughs KL, Halsey WA Jr, Howell MD. Multifaceted inhibition of anti-tumour immune mechanisms by soluble tumour necrosis factor receptor type I. Immunology 1998;94:88-93. [PMID: 9708191 DOI: 10.1046/j.1365-2567.1998.00481.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
152 Koh Y, Hybertson BM, Jepson EK, Repine JE. Tumor necrosis factor induced acute lung leak in rats: Less than with interleukin-1. Inflammation 1996;20:461-9. [DOI: 10.1007/bf01487039] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
153 Solorzano CC, Kaibara A, Hess PJ, Edwards PD, Ksontini R, Abouhamze A, McDaniel S, Frazier J, Trujillo D, Kieft G, Seely J, Kohno T, Cosenza ME, Clare-Salzler M, MacKay SL, Martin SW, Moldawer LL, Edwards CK 3rd. Pharmacokinetics, immunogenicity, and efficacy of dimeric TNFR binding proteins in healthy and bacteremic baboon. J Appl Physiol (1985) 1998;84:1119-30. [PMID: 9516174 DOI: 10.1152/jappl.1998.84.4.1119] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.1] [Reference Citation Analysis]
154 Swain SD, Rohn TT, Quinn MT. Neutrophil priming in host defense: role of oxidants as priming agents. Antioxid Redox Signal 2002;4:69-83. [PMID: 11970845 DOI: 10.1089/152308602753625870] [Cited by in Crossref: 129] [Cited by in F6Publishing: 123] [Article Influence: 6.5] [Reference Citation Analysis]
155 Sommer C, Schmidt C, George A, Toyka KV. A metalloprotease-inhibitor reduces pain associated behavior in mice with experimental neuropathy. Neuroscience Letters 1997;237:45-8. [DOI: 10.1016/s0304-3940(97)00813-6] [Cited by in Crossref: 64] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
156 Shibata M, Takekawa M, Amano S. Increased serum concentrations of soluble tumor necrosis factor receptor I in noncachectic and cachectic patients with advanced gastric and colorectal cancer. Surg Today 1998;28:884-8. [DOI: 10.1007/s005950050247] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
157 Olszyna DP, Prins JM, Buis B, van Deventer SJH, Speelman P, van der Poll T. Levels of Inhibitors of Tumor Necrosis Factor Alpha and Interleukin 1β in Urine and Sera of Patients with Urosepsis. Infect Immun 1998;66:3527-34. [DOI: 10.1128/iai.66.8.3527-3534.1998] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
158 Ware CF, VanArsdale TL, Crowe PD, Browning JL. The ligands and receptors of the lymphotoxin system. Curr Top Microbiol Immunol 1995;198:175-218. [PMID: 7774281 DOI: 10.1007/978-3-642-79414-8_11] [Cited by in Crossref: 59] [Cited by in F6Publishing: 94] [Article Influence: 2.2] [Reference Citation Analysis]
159 van der Poll T, van Deventer SJ. Cytokines and anticytokines in the pathogenesis of sepsis. Infect Dis Clin North Am 1999;13:413-26, ix. [PMID: 10340175 DOI: 10.1016/s0891-5520(05)70083-0] [Cited by in Crossref: 217] [Cited by in F6Publishing: 57] [Article Influence: 9.4] [Reference Citation Analysis]
160 Perucci LO, Vieira ÉLM, Teixeira AL, Gomes KB, Dusse LM, Sousa LP. Decreased plasma concentrations of brain-derived neurotrophic factor in preeclampsia. Clinica Chimica Acta 2017;464:142-7. [DOI: 10.1016/j.cca.2016.11.034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
161 Loffreda S, Muratori P, Muratori L, Mele L, Bianchi FB, Lenzi M. Enhanced monocyte Th1 cytokine production in HCV-infected cryoglobulinemic patients. J Hepatol 2003;38:230-6. [PMID: 12547413 DOI: 10.1016/s0168-8278(02)00353-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
162 Wilson S, Dunne DW. Advances in our understanding of the epidemiology of Plasmodium and schistosome infection: informing coinfection studies. Curr Opin HIV AIDS 2012;7:225-30. [PMID: 22327411 DOI: 10.1097/COH.0b013e328351b9fb] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
163 Davies MG, Hagen PO. Systemic inflammatory response syndrome. Br J Surg. 1997;84:920-935. [PMID: 9240130 DOI: 10.1002/bjs.1800840707] [Cited by in Crossref: 302] [Cited by in F6Publishing: 271] [Article Influence: 12.1] [Reference Citation Analysis]
164 Jostock T, Blinn G, Renné C, Kallen K, Rose-john S, Müllberg J. Immunoadhesins of interleukin-6 and the IL-6/soluble IL-6R fusion protein hyper-IL-6. Journal of Immunological Methods 1999;223:171-83. [DOI: 10.1016/s0022-1759(98)00218-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
165 De Vries MR, Borel Rinkes IH, Swaak AJ, Hack CE, Van De Velde CJ, Wiggers T, Tollenaar RA, Kuppen PJ, Eggermont AM. Acute-phase response patterns in isolated hepatic perfusion with tumour necrosis factor alpha (TNF-alpha) and melphalan in patients with colorectal liver metastases. Eur J Clin Invest. 1999;29:553-560. [PMID: 10354218 DOI: 10.1046/j.1365-2362.1999.00480.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
166 Huang ZS, Chiang BL, Hsu KL. Serum level of soluble tumor necrosis factor receptor II (sTNF-R75) is apparently an index of overall monocyte-related infectious and inflammatory activity. Am J Med Sci 2000;320:183-7. [PMID: 11014372 DOI: 10.1097/00000441-200009000-00009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.0] [Reference Citation Analysis]
167 Parameswaran N, Patial S. Tumor necrosis factor-α signaling in macrophages. Crit Rev Eukaryot Gene Expr 2010;20:87-103. [PMID: 21133840 DOI: 10.1615/critreveukargeneexpr.v20.i2.10] [Cited by in Crossref: 641] [Cited by in F6Publishing: 342] [Article Influence: 58.3] [Reference Citation Analysis]
168 Schlüter D, Deckert M. The divergent role of tumor necrosis factor receptors in infectious diseases. Microbes Infect 2000;2:1285-92. [PMID: 11008118 DOI: 10.1016/s1286-4579(00)01282-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
169 Levandowski ML, Viola TW, Wearick-Silva LE, Wieck A, Tractenberg SG, Brietzke E, Bauer ME, Teixeira AL, Grassi-Oliveira R. Early life stress and tumor necrosis factor superfamily in crack cocaine withdrawal. J Psychiatr Res 2014;53:180-6. [PMID: 24631195 DOI: 10.1016/j.jpsychires.2014.02.017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
170 Ye Q, Dai H, Sarria R, Guzman J, Costabel U. Increased expression of tumor necrosis factor receptors in cryptogenic organizing pneumonia. Respir Med 2011;105:292-7. [PMID: 21144722 DOI: 10.1016/j.rmed.2010.10.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
171 Alvarez JA, Higgins PB, Oster RA, Fernandez JR, Darnell BE, Gower BA. Fasting and postprandial markers of inflammation in lean and overweight children. Am J Clin Nutr 2009;89:1138-44. [PMID: 19211818 DOI: 10.3945/ajcn.2008.26926] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
172 Lowry SF, Vanzee KJ, Moldawer LL. Strategies for Modulation of Systemic and Tissue Cytokine Responses to Sepsis. In: Lamy M, Thijs LG, editors. Mediators of Sepsis. Berlin: Springer Berlin Heidelberg; 1992. pp. 345-61. [DOI: 10.1007/978-3-642-84827-8_25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
173 Vary TC, Deiter G, Lang CH. Diminished ERK 1/2 and p38 MAPK phosphorylation in skeletal muscle during sepsis. Shock 2004;22:548-54. [PMID: 15545827 DOI: 10.1097/01.shk.0000144131.13900.ff<] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
174 Darville T, Giroir B, Jacobs R. The systemic inflammatory response syndrome (SIRS): immunology and potential immunotherapy. Infection 1993;21:279-90. [PMID: 8300243 DOI: 10.1007/BF01712446] [Cited by in Crossref: 42] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
175 Webster NR, Galley HF. Immunomodulation in the critically ill. Br J Anaesth 2009;103:70-81. [PMID: 19474216 DOI: 10.1093/bja/aep128] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
176 Ando K, Kato H, Kotani T, Ozaki M, Arimura Y, Yagi J. Plasma leukocyte cell-derived chemotaxin 2 is associated with the severity of systemic inflammation in patients with sepsis: Leukocyte cell-derived chemotaxin 2 in sepsis. Microbiology and Immunology 2012;56:708-18. [DOI: 10.1111/j.1348-0421.2012.00488.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
177 Wang J, Al-Lamki RS. Tumor necrosis factor receptor 2: its contribution to acute cellular rejection and clear cell renal carcinoma. Biomed Res Int 2013;2013:821310. [PMID: 24350291 DOI: 10.1155/2013/821310] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
178 Grzanka R, Damasiewicz-Bodzek A, Kasperska-Zajac A. Tumor necrosis factor-alpha and Fas/Fas ligand signaling pathways in chronic spontaneous urticaria. Allergy Asthma Clin Immunol 2019;15:15. [PMID: 30911316 DOI: 10.1186/s13223-019-0332-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
179 Wallace HJ, Stacey MC. Levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in chronic venous leg ulcers--correlations to healing status. J Invest Dermatol. 1998;110:292-296. [PMID: 9506452 DOI: 10.1046/j.1523-1747.1998.00113.x] [Cited by in Crossref: 105] [Cited by in F6Publishing: 103] [Article Influence: 4.4] [Reference Citation Analysis]
180 Vielhauer V, Mayadas TN. Functions of TNF and its receptors in renal disease: distinct roles in inflammatory tissue injury and immune regulation. Semin Nephrol. 2007;27:286-308. [PMID: 17533007 DOI: 10.1016/j.semnephrol.2007.02.004] [Cited by in Crossref: 79] [Cited by in F6Publishing: 75] [Article Influence: 5.3] [Reference Citation Analysis]
181 Ferrari R. THE ROLE OF TNF IN CARDIOVASCULAR DISEASE. Pharmacological Research 1999;40:97-105. [DOI: 10.1006/phrs.1998.0463] [Cited by in Crossref: 112] [Cited by in F6Publishing: 99] [Article Influence: 4.9] [Reference Citation Analysis]
182 Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest. 2000;117:1162-1172. [PMID: 10767254 DOI: 10.1378/chest.117.4.1162] [Cited by in Crossref: 881] [Cited by in F6Publishing: 802] [Article Influence: 40.0] [Reference Citation Analysis]
183 Leroy EM, Baize S, Debre P, Lansoud-Soukate J, Mavoungou E. Early immune responses accompanying human asymptomatic Ebola infections. Clin Exp Immunol 2001;124:453-60. [PMID: 11472407 DOI: 10.1046/j.1365-2249.2001.01517.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 94] [Article Influence: 5.1] [Reference Citation Analysis]
184 Roth J, Mcclellan JL, Kluger MJ, Zeisberger E. Changes in body temperature and circulating levels of interleukin-6 after intra-arterial injections or infusions of tumor necrosis factor α in guinea pigs. Experientia 1994;50:815-20. [DOI: 10.1007/bf01956462] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
185 van Dielen F, van't Veer C, Schols A, Soeters P, Buurman W, Greve J. Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int J Obes 2001;25:1759-66. [DOI: 10.1038/sj.ijo.0801825] [Cited by in Crossref: 134] [Cited by in F6Publishing: 124] [Article Influence: 6.4] [Reference Citation Analysis]
186 Roth J, Martin D, Störr B, Zeisberger E. Neutralization of pyrogen-induced tumour necrosis factor by its type 1 soluble receptor in guinea-pigs: effects on fever and interleukin-6 release. J Physiol 1998;509 ( Pt 1):267-75. [PMID: 9547399 DOI: 10.1111/j.1469-7793.1998.267bo.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 2.4] [Reference Citation Analysis]
187 Lee RH, Efron DT, Tantry U, Stuelten C, Moldawer LL, Abouhamze A, Barbul A. Inhibition of tumor necrosis factor-alpha attenuates wound breaking strength in rats. Wound Repair Regen 2000;8:547-53. [PMID: 11208182 DOI: 10.1046/j.1524-475x.2000.00547.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 2.5] [Reference Citation Analysis]
188 Rzymski T, Petry A, Kračun D, Rieß F, Pike L, Harris AL, Görlach A. The unfolded protein response controls induction and activation of ADAM17/TACE by severe hypoxia and ER stress. Oncogene 2012;31:3621-34. [DOI: 10.1038/onc.2011.522] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
189 Phillips NA, Welc SS, Wallet SM, King MA, Clanton TL. Protection of intestinal injury during heat stroke in mice by interleukin-6 pretreatment. J Physiol 2015;593:739-52; discussion 753. [PMID: 25433073 DOI: 10.1113/jphysiol.2014.283416] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
190 Tilg H, Jalan R, Kaser A, Davies NA, Offner FA, Hodges SJ, Ludwiczek O, Shawcross D, Zoller H, Alisa A. Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. J Hepatol. 2003;38:419-425. [PMID: 12663232 DOI: 10.1016/s0168-8278(02)00442-7] [Cited by in Crossref: 162] [Cited by in F6Publishing: 53] [Article Influence: 8.5] [Reference Citation Analysis]
191 Roth J, McClellan JL, Kluger MJ, Zeisberger E. Attenuation of fever and release of cytokines after repeated injections of lipopolysaccharide in guinea-pigs. J Physiol 1994;477:177-85. [PMID: 8071885 DOI: 10.1113/jphysiol.1994.sp020182] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 2.6] [Reference Citation Analysis]
192 Lentz MR. The role of therapeutic apheresis in the treatment of cancer: a review. Ther Apher 1999;3:40-9. [PMID: 10079805 DOI: 10.1046/j.1526-0968.1999.00147.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
193 Kern WV, Engel A, Kern P. Soluble tumor necrosis factor receptors in febrile neutropenic cancer patients. Infection 1995;23:64-5. [DOI: 10.1007/bf01710064] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
194 Schetz M, Ferdinande P, Van den Berghe G, Verwaest C, Lauwers P. Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense? Intensive Care Med 1995;21:169-76. [PMID: 7775699 DOI: 10.1007/BF01726541] [Cited by in Crossref: 95] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
195 Carrol ED, Thomson AP, Jones AP, Jeffers G, Hart CA. A predominantly anti-inflammatory cytokine profile is associated with disease severity in meningococcal sepsis. Intensive Care Med 2005;31:1415-9. [PMID: 16132884 DOI: 10.1007/s00134-005-2787-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
196 Fearns C, Loskutoff DJ. Role of tumor necrosis factor alpha in induction of murine CD14 gene expression by lipopolysaccharide. Infect Immun 1997;65:4822-31. [DOI: 10.1128/iai.65.11.4822-4831.1997] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
197 Skerrett SJ, Martin TR, Chi EY, Peschon JJ, Mohler KM, Wilson CB. Role of the type 1 TNF receptor in lung inflammation after inhalation of endotoxin or Pseudomonas aeruginosa. Am J Physiol 1999;276:L715-27. [PMID: 10330027 DOI: 10.1152/ajplung.1999.276.5.L715] [Cited by in Crossref: 30] [Cited by in F6Publishing: 39] [Article Influence: 1.3] [Reference Citation Analysis]
198 Mano A, Fujita K, Uenomachi K, Kazama K, Katabuchi M, Wada K, Terakawa N, Arai K, Hori Y, Hashimoto S, Nakatani T, Kitamura S. Body Mass Index is a Useful Predictor of Prognosis After Left Ventricular Assist System Implantation. The Journal of Heart and Lung Transplantation 2009;28:428-33. [DOI: 10.1016/j.healun.2008.12.020] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 3.7] [Reference Citation Analysis]
199 Figenschau Y, Sveinbjörnsson B, Bertheussen K. Improvement of a cytokine (TNF-α) bioassay by serum-free target cell (WEHI 164) cultivation. Cytotechnology 1999;29:121-34. [PMID: 22359061 DOI: 10.1023/A:1008052307547] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
200 Livingston DH, Deitch EA. Multiple organ failure: a common problem in surgical intensive care unit patients. Ann Med 1995;27:13-20. [PMID: 7741992 DOI: 10.3109/07853899509031931] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 1.1] [Reference Citation Analysis]
201 King W, Bendele A, Marohl T, Woodell-May J. Human blood-based anti-inflammatory solution inhibits osteoarthritis progression in a meniscal-tear rat study. J Orthop Res 2017;35:2260-8. [PMID: 28139016 DOI: 10.1002/jor.23528] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
202 Romero R, Maymon E, Pacora P, Gomez R, Mazor M, Yoon BH, Berry SM. Further observations on the fetal inflammatory response syndrome: a potential homeostatic role for the soluble receptors of tumor necrosis factor alpha. Am J Obstet Gynecol 2000;183:1070-7. [PMID: 11084543 DOI: 10.1067/mob.2000.108885] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 2.3] [Reference Citation Analysis]
203 Evans TJ, Moyes D, Carpenter A, Martin R, Loetscher H, Lesslauer W, Cohen J. Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis. J Exp Med 1994;180:2173-9. [PMID: 7964492 DOI: 10.1084/jem.180.6.2173] [Cited by in Crossref: 119] [Cited by in F6Publishing: 101] [Article Influence: 4.3] [Reference Citation Analysis]
204 Lowry SF, Moldawer LL. Modulation of cytokine responses in sepsis. Ann N Y Acad Sci 1993;685:471-82. [PMID: 8363256 DOI: 10.1111/j.1749-6632.1993.tb35909.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
205 Ono Y, Watanabe T, Matsumoto K, Ito T, Kunii O, Goldstein E. Opsonophagocytic dysfunction in patients with liver cirrhosis and low responses to tumor necrosis factor-alpha and lipopolysaccharide in patients’ blood. J Infect Chemother. 2004;10:200-207. [PMID: 15365859 DOI: 10.1007/s10156-004-0321-7] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
206 Darniot M, Pitoiset C, Petrella T, Aho S, Pothier P, Manoha C. Age-associated aggravation of clinical disease after primary metapneumovirus infection of BALB/c mice. J Virol 2009;83:3323-32. [PMID: 19144706 DOI: 10.1128/JVI.02198-08] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
207 Rojas-cartagena C, Appleyard CB, Santiago OI, Flores I. Experimental Intestinal Endometriosis Is Characterized by Increased Levels of Soluble TNFRSF1B and Downregulation of Tnfrsf1a and Tnfrsf1b Gene Expression1. Biology of Reproduction 2005;73:1211-8. [DOI: 10.1095/biolreprod.105.044131] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
208 Cavaillon J. Possibilities and problems of cytokine measurements. In: Redl H, Schlag G, editors. Cytokines in Severe Sepsis and Septic Shock. Basel: Birkhäuser; 1999. pp. 95-119. [DOI: 10.1007/978-3-0348-8755-7_6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
209 Hashim IA. Clinical biochemistry of hyperthermia. Ann Clin Biochem 2010;47:516-23. [PMID: 20926467 DOI: 10.1258/acb.2010.010186] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
210 Waage A, Steinshamn S. Cytokine mediators of septic infections in the normal and granulocytopenic host. European Journal of Haematology 1993;50:243-9. [DOI: 10.1111/j.1600-0609.1993.tb00156.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
211 Fearon KC, Falconer JS, Slater C, McMillan DC, Ross JA, Preston T. Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response. Ann Surg 1998;227:249-54. [PMID: 9488524 DOI: 10.1097/00000658-199802000-00015] [Cited by in Crossref: 122] [Cited by in F6Publishing: 104] [Article Influence: 5.1] [Reference Citation Analysis]
212 Woodell-May J, Steckbeck K, King W. Potential Mechanism of Action of Current Point-of-Care Autologous Therapy Treatments for Osteoarthritis of the Knee-A Narrative Review. Int J Mol Sci 2021;22:2726. [PMID: 33800401 DOI: 10.3390/ijms22052726] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
213 Moldoveanu AI, Shephard RJ, Shek PN. The cytokine response to physical activity and training. Sports Med 2001;31:115-44. [PMID: 11227979 DOI: 10.2165/00007256-200131020-00004] [Cited by in Crossref: 147] [Cited by in F6Publishing: 127] [Article Influence: 7.0] [Reference Citation Analysis]
214 Cauley JA, Danielson ME, Boudreau RM, Forrest KY, Zmuda JM, Pahor M, Tylavsky FA, Cummings SR, Harris TB, Newman AB; Health ABC Study. Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study. J Bone Miner Res 2007;22:1088-95. [PMID: 17419681 DOI: 10.1359/jbmr.070409] [Cited by in Crossref: 158] [Cited by in F6Publishing: 152] [Article Influence: 10.5] [Reference Citation Analysis]
215 Faber C, Jehs T, Juel HB, Singh A, Falk MK, Sørensen TL, Nissen MH. Early and exudative age‐related macular degeneration is associated with increased plasma levels of soluble TNF receptor II. Acta Ophthalmol 2014;93:242-7. [DOI: 10.1111/aos.12581] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
216 Lowry SF. The evolution of an inflammatory response. Surg Infect (Larchmt) 2009;10:419-25. [PMID: 19792838 DOI: 10.1089/sur.2009.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
217 Sakamoto K, Hisano S, Kamohara H, Ishiko T, Mita S, Ogawa M. Changes of interleukin 6 and soluble IL-6 receptor levels after surgery. International Congress Series 2003;1255:135-42. [DOI: 10.1016/s0531-5131(03)00654-x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
218 Mwangi SM, Stabel TJ, Kehrli ME. Development of a baculovirus expression system for soluble porcine tumor necrosis factor receptor type I and soluble porcine tumor necrosis factor receptor type I-IgG fusion protein. Veterinary Immunology and Immunopathology 2002;86:251-4. [DOI: 10.1016/s0165-2427(02)00034-x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
219 Gough M, Hancock RE, Kelly NM. Antiendotoxin activity of cationic peptide antimicrobial agents. Infect Immun 1996;64:4922-7. [PMID: 8945527 DOI: 10.1128/iai.64.12.4922-4927.1996] [Cited by in Crossref: 186] [Cited by in F6Publishing: 68] [Article Influence: 7.4] [Reference Citation Analysis]
220 Ward R, McLeish KR. Soluble TNF alpha receptors are increased in chronic renal insufficiency and hemodialysis and inhibit neutrophil priming by TNF alpha. Artif Organs 1996;20:390-5. [PMID: 8725616 DOI: 10.1111/j.1525-1594.1996.tb04521.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
221 Liu Z, Wyffels L, Barber C, Wan L, Xu H, Hui MM, Furenlid LR, Woolfenden JM. Characterization of 99mTc-labeled cytokine ligands for inflammation imaging via TNF and IL-1 pathways. Nucl Med Biol 2012;39:905-15. [PMID: 22749187 DOI: 10.1016/j.nucmedbio.2012.05.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
222 Nagai H, Kanekawa T, Kobayashi K, Mukozu T, Matsui D, Matsui T, Kanayama M, Wakui N, Momiyama K, Shinohara M, Ishii K, Igarashi Y, Sumino Y. Changes of cytokines in patients with liver cirrhosis and advanced hepatocellular carcinoma treated by sorafenib. Cancer Chemother Pharmacol 2014;73:223-9. [PMID: 24220937 DOI: 10.1007/s00280-013-2344-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
223 Stiller-winkler R, Hadnagy W, Leng G, Straube E, Idel H. Immunological parameters in humans exposed to pesticides in the agricultural environment. Toxicology Letters 1999;107:219-24. [DOI: 10.1016/s0378-4274(99)00050-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
224 Gibot S, Massin F, Le Renard P, Béné MC, Faure GC, Bollaert PE, Levy B. Surface and soluble triggering receptor expressed on myeloid cells-1: expression patterns in murine sepsis. Crit Care Med 2005;33:1787-93. [PMID: 16096457 DOI: 10.1097/01.ccm.0000172614.36571.75] [Cited by in Crossref: 45] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
225 Friedland JS, Porter JC, Daryanani S, Bland JM, Screaton NJ, Vesely MJJ, Griffin GE, Bennett ED, Remick DG. Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit: . Critical Care Medicine 1996;24:1775-81. [DOI: 10.1097/00003246-199611000-00003] [Cited by in Crossref: 85] [Cited by in F6Publishing: 80] [Article Influence: 3.3] [Reference Citation Analysis]
226 Rathore VB, Advani SH, Nadkarni JJ. High cytosolic pool of p75 TNF receptors and delayed surface downmodulation by mononuclear cells from non-hodgkin's lymphoma patients. Cytokine 2000;12:1142-6. [PMID: 10880265 DOI: 10.1006/cyto.1999.0651] [Reference Citation Analysis]
227 Botchkina GI, Meistrell ME, Botchkina IL, Tracey KJ. Expression of TNF and TNF Receptors (p55 and p75) in the Rat Brain after Focal Cerebral Ischemia. Mol Med 1997;3:765-81. [DOI: 10.1007/bf03401714] [Cited by in Crossref: 195] [Article Influence: 7.8] [Reference Citation Analysis]
228 Tosi GM, Marigliani D, Romeo N, Toti P. Disease pathways in proliferative vitreoretinopathy: an ongoing challenge. J Cell Physiol 2014;229:1577-83. [PMID: 24604697 DOI: 10.1002/jcp.24606] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
229 Landow L, Andersen LW. Splanchnic ischemia and its role in multiple organ failure. Acta Anaesthesiol Scand. 1994;38:626-639. [PMID: 7839769 DOI: 10.1111/j.1399-6576.1994.tb03969.x] [Cited by in Crossref: 120] [Cited by in F6Publishing: 102] [Article Influence: 4.4] [Reference Citation Analysis]
230 Henderson B, Poole S. Modulation of Cytokine Function: Therapeutic Applications. Elsevier; 1994. pp. 53-115. [DOI: 10.1016/s1054-3589(08)60430-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
231 Yu XW, Zhang XW, Li X. Soluble tumor necrosis factor receptor mediates cell proliferation on lipopolysaccharide-stimulated cultured human decidual stromal cells. Int J Mol Sci 2009;10:2010-8. [PMID: 19564935 DOI: 10.3390/ijms10052010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
232 Martich GD, Boujoukos AJ, Suffredini AF. Response of man to endotoxin. Immunobiology 1993;187:403-16. [PMID: 8330905 DOI: 10.1016/S0171-2985(11)80353-0] [Cited by in Crossref: 183] [Cited by in F6Publishing: 53] [Article Influence: 6.3] [Reference Citation Analysis]
233 Wolf R, Matz H, Orion E, Ruocco V. Anti-TNF therapies—the hope of tomorrow. Clinics in Dermatology 2002;20:522-30. [DOI: 10.1016/s0738-081x(02)00273-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
234 Uehara J, Kuboki T, Fujisawa T, Kojima S, Maekawa K, Yatani H. Soluble tumour necrosis factor receptors in synovial fluids from temporomandibular joints with painful anterior disc displacement without reduction and osteoarthritis. Archives of Oral Biology 2004;49:133-42. [DOI: 10.1016/j.archoralbio.2003.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
235 Hartung H, Reiners K, Archelos JJ, Michels M, Seeldrayers P, Heidenreich F, Pflughaupt KW, Toyka KV. Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: Correlation with magnetic resonance imaging. Ann Neurol 1995;38:186-93. [DOI: 10.1002/ana.410380210] [Cited by in Crossref: 120] [Cited by in F6Publishing: 102] [Article Influence: 6.7] [Reference Citation Analysis]
236 Cackovic M, Buhimschi CS, Zhao G, Funai EF, Norwitz ER, Kuczynski E, Lockwood CJ, Buhimschi IA. Fractional excretion of tumor necrosis factor-alpha in women with severe preeclampsia. Obstet Gynecol 2008;112:93-100. [PMID: 18591313 DOI: 10.1097/AOG.0b013e31817c4304] [Cited by in Crossref: 36] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
237 Baize S, Leroy EM, Georges AJ, Georges-Courbot MC, Capron M, Bedjabaga I, Lansoud-Soukate J, Mavoungou E. Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol 2002;128:163-8. [PMID: 11982604 DOI: 10.1046/j.1365-2249.2002.01800.x] [Cited by in Crossref: 239] [Cited by in F6Publishing: 223] [Article Influence: 12.0] [Reference Citation Analysis]
238 Penninx BWJH, Kritchevsky SB, Newman AB, Nicklas BJ, Simonsick EM, Rubin S, Nevitt M, Visser M, Harris T, Pahor M. Inflammatory Markers and Incident Mobility Limitation in the Elderly: INFLAMMATION AND INCIDENT MOBILITY LIMITATION. Journal of the American Geriatrics Society 2004;52:1105-13. [DOI: 10.1111/j.1532-5415.2004.52308.x] [Cited by in Crossref: 212] [Cited by in F6Publishing: 193] [Article Influence: 11.8] [Reference Citation Analysis]
239 Otterlei M, Sundan A, Ryan L, Espevik T. Effects of Anti-CD 18 and LPS on CD 14 Expression on Human Monocytes. Scand J Immunol 1995;41:583-92. [DOI: 10.1111/j.1365-3083.1995.tb03611.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
240 Arntzen KJ, Liabakk N, Jacobsen G, Espevik T, Austgulen R. Soluble Tumor Necrosis Factor Receptor in Serum and Urine Throughout Normal Pregnancy and at Delivery. American Journal of Reproductive Immunology 1995;34:163-9. [DOI: 10.1111/j.1600-0897.1995.tb00933.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
241 Winter M. Preclinical Safety Assessment of the Recombinant TNF Receptor–Immunoglobulin Fusion Protein. Clinical Immunology and Immunopathology 1997;83:21-4. [DOI: 10.1006/clin.1996.4307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
242 Pinto LM, Oliveira SA, Braga EL, Nogueira RM, Kubelka CF. Increased pro-inflammatory cytokines (TNF-alpha and IL-6) and anti-inflammatory compounds (sTNFRp55 and sTNFRp75) in Brazilian patients during exanthematic dengue fever. Mem Inst Oswaldo Cruz 1999;94:387-94. [PMID: 10348988 DOI: 10.1590/s0074-02761999000300019] [Cited by in Crossref: 41] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
243 Kanaoka Y, Yagi T, Sadamori H, Matsukawa H, Matsuda H, Inagaki M, Ishikawa T, Saito S, Iwagaki H, Tanaka N. Analysis of Host Response to Hepatectomy by Simultaneous Measurement of Cytokines in the Portal Vein, Caval Vein and Radial Artery. J Int Med Res 2002;30:496-505. [DOI: 10.1177/147323000203000505] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
244 Medvedev AE, Espevik T, Ranges G, Sundan A. Distinct roles of the two tumor necrosis factor (TNF) receptors in modulating TNF and lymphotoxin alpha effects. J Biol Chem 1996;271:9778-84. [PMID: 8621658 DOI: 10.1074/jbc.271.16.9778] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 2.5] [Reference Citation Analysis]
245 Sinha P, Ware LB. Selective tumour necrosis factor receptor-1 inhibition in acute lung injury: a new hope or a false dawn? Thorax 2018;73:699-701. [PMID: 29567751 DOI: 10.1136/thoraxjnl-2017-211443] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
246 Wu IC, Hsu CC, Chen CY, Chuang SC, Cheng CW, Hsieh WS, Wu MS, Liu YT, Liu YH, Tsai TL, Lin CC, Hsiung CA. Paradoxical Relationship Between Glycated Hemoglobin and Longitudinal Change in Physical Functioning in Older Adults: A Prospective Cohort Study. J Gerontol A Biol Sci Med Sci 2019;74:949-56. [PMID: 31095709 DOI: 10.1093/gerona/gly147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
247 Pereira BJ, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA. Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 1994;45:890-6. [PMID: 8196293 DOI: 10.1038/ki.1994.117] [Cited by in Crossref: 265] [Cited by in F6Publishing: 243] [Article Influence: 9.5] [Reference Citation Analysis]
248 Moradi MM, Carson LF, Twiggs LB, Weinberg JB, Haney AF, Ramakrishnan S. Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer. Cancer 1993;72:2433-40. [DOI: 10.1002/1097-0142(19931015)72:8<2433::aid-cncr2820720822>3.0.co;2-l] [Cited by in Crossref: 102] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
249 Welborn MB 3rd, Van Zee K, Edwards PD, Pruitt JH, Kaibara A, Vauthey JN, Rogy M, Castleman WL, Lowry SF, Kenney JS, Stüber D, Ettlin U, Wipf B, Loetscher H, Copeland EM 3rd, Lesslauer W, Moldawer LL. A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon. J Exp Med 1996;184:165-71. [PMID: 8691130 DOI: 10.1084/jem.184.1.165] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 1.5] [Reference Citation Analysis]
250 Fang WH, Yao YM, Shi ZG, Yu Y, Wu Y, Lu LR, Sheng ZY. The mRNA expression patterns of tumor necrosis factor-α and TNFR-I in some vital organs after thermal injury. World J Gastroenterol 2003; 9(5): 1038-1044 [PMID: 12717852 DOI: 10.3748/wjg.v9.i5.1038] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
251 Sibai B, Romero R, Klebanoff MA, Rice MM, Caritis S, Lindheimer MD, Van Dorsten JP, Landon M, Miodovnik M, Dombrowski M, Meis P; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia. Am J Obstet Gynecol 2009;200:630.e1-8. [PMID: 19306961 DOI: 10.1016/j.ajog.2009.01.033] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
252 Sponholtz TR, Zhang X, Fontes JD, Meigs JB, Cupples LA, Kiel DP, Hannan MT, McLean RR. Association between inflammatory biomarkers and bone mineral density in a community-based cohort of men and women. Arthritis Care Res (Hoboken) 2014;66:1233-40. [PMID: 24375982 DOI: 10.1002/acr.22270] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
253 Wei M, Kuukasjärvi P, Laurikka J, Pehkonen E, Kaukinen S, Laine S, Tarkka M. INFLAMMATORY CYTOKINES AND SOLUBLE RECEPTORS AFTER CORONARY ARTERY BYPASS GRAFTING. Cytokine 2001;15:223-8. [DOI: 10.1006/cyto.2001.0920] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
254 Hoare GS, Birks EJ, Bowles C, Marczin N, Yacoub MH. In vitro endothelial cell activation and inflammatory responses in end-stage heart failure. J Appl Physiol (1985) 2006;101:1466-73. [PMID: 16825515 DOI: 10.1152/japplphysiol.01497.2005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
255 Cox FA, Stiller-winkler R, Hadnagy W, Ranft U, Idel H. Soluble tumor necrosis factor receptor (sTNF RII) in sera of children and traffic-derived particulate air pollution. Zentralblatt für Hygiene und Umweltmedizin 1999;202:489-500. [DOI: 10.1016/s0934-8859(99)80038-8] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
256 Fraunberger P, Schaefer S, Werdan K, Walli AK, Seidel D. Reduction of Circulating Cholesterol and Apolipoprotein Levels during Sepsis. Clinical Chemistry and Laboratory Medicine 1999;37. [DOI: 10.1515/cclm.1999.059] [Cited by in Crossref: 49] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
257 Woodell-may J, Matuska A, Oyster M, Welch Z, O'shaughnessey K, Hoeppner J. Autologous protein solution inhibits MMP-13 production by IL-1β and TNFα-stimulated human articular chondrocytes: APS INHIBITS MMP-13 IN CHONDROCYTES. J Orthop Res 2011;29:1320-6. [DOI: 10.1002/jor.21384] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 6.8] [Reference Citation Analysis]
258 Sheu BC, Lin HH, Chang DY, Ho HN, Huang SC. The potential of serum levels of soluble tumour necrosis factor receptor I as a biochemical marker in cervical cancer. Br J Obstet Gynaecol 1997;104:1314-9. [PMID: 9386035 DOI: 10.1111/j.1471-0528.1997.tb10981.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.0] [Reference Citation Analysis]
259 Ribeiro AF, Nobre V, Neuenschwander LC, Teixeira AL, Xavier SG, Paula FD, Teixeira MM, Teixeira JC, Bittencourt H. Use of inflammatory molecules to predict the occurrence of fever in onco-hematological patients with neutropenia. Braz J Med Biol Res 2013;46:200-6. [PMID: 23369970 DOI: 10.1590/1414-431x20122397] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
260 Hufford MM, Kim TS, Sun J, Braciale TJ. The effector T cell response to influenza infection. Curr Top Microbiol Immunol 2015;386:423-55. [PMID: 25033753 DOI: 10.1007/82_2014_397] [Cited by in Crossref: 15] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
261 Spielmann S, Kerner T, Ahlers O, Keh D, Gerlach M, Gerlach H. Early detection of increased tumour necrosis factor alpha (TNFalpha) and soluble TNF receptor protein plasma levels after trauma reveals associations with the clinical course. Acta Anaesthesiol Scand. 2001;45:364-370. [PMID: 11207475 DOI: 10.1034/j.1399-6576.2001.045003364.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 2.2] [Reference Citation Analysis]
262 Taylor FB. Staging of the pathophysiologic responses of the primate microvasculature to Escherichia coli and endotoxin: Examination of the elements of the compensated response and their links to the corresponding uncompensated lethal variants: . Critical Care Medicine 2001;29:S78-89. [DOI: 10.1097/00003246-200107001-00026] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 2.7] [Reference Citation Analysis]
263 Bolling SF. Mitral valve reconstruction in the patient with heart failure. Heart Fail Rev 2001;6:177-85. [PMID: 11391035 DOI: 10.1023/a:1011421014480] [Cited by in Crossref: 25] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
264 Waage A, Espevik T. TNF Receptors in Chronic Lymphocytic Leukemia. Leukemia & Lymphoma 2009;13:41-6. [DOI: 10.3109/10428199409051650] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
265 Josephs MD, Bahjat FR, Fukuzuka K, Ksontini R, Solorzano CC, Edwards CK 3rd, Tannahill CL, MacKay SL, Copeland EM 3rd, Moldawer LL. Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-alpha and not by Fas ligand. Am J Physiol Regul Integr Comp Physiol 2000;278:R1196-201. [PMID: 10801287 DOI: 10.1152/ajpregu.2000.278.5.R1196] [Cited by in Crossref: 77] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
266 Fukui H. Cytokines in Hepatic Injury. Liver Pathophysiology. Elsevier; 2017. pp. 341-54. [DOI: 10.1016/b978-0-12-804274-8.00027-8] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
267 Sessler CN, Bloomfield GL, Fowler AA. CURRENT CONCEPTS OF SEPSIS AND ACUTE LUNG INJURY. Clinics in Chest Medicine 1996;17:213-35. [DOI: 10.1016/s0272-5231(05)70310-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
268 Norman KE, Williams TJ, Feldmann M, Rossi AG. Effect of soluble P55 tumour-necrosis factor binding fusion protein on the local Shwartzman and Arthus reactions. Br J Pharmacol 1996;117:471-8. [PMID: 8821536 DOI: 10.1111/j.1476-5381.1996.tb15214.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
269 Ostermann H, Rothenburger M, Mesters RM, Loo J, Kienast J. Cytokine response to infection in patients with acute myelogenous leukaemia following intensive chemotherapy. Br J Haematol 1994;88:332-7. [DOI: 10.1111/j.1365-2141.1994.tb05027.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 1.4] [Reference Citation Analysis]
270 Rodriguez-Fernandez M, Grosman B, Yuraszeck TM, Helwig BG, Leon LR, Doyle FJ 3rd. Modeling the intra- and extracellular cytokine signaling pathway under heat stroke in the liver. PLoS One 2013;8:e73393. [PMID: 24039931 DOI: 10.1371/journal.pone.0073393] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
271 Malamitsi-puchner A, Protonotariou E, Boutsikou T, Makrakis E, Sarandakou A, Creatsas G. The influence of the mode of delivery on circulating cytokine concentrations in the perinatal period. Early Human Development 2005;81:387-92. [DOI: 10.1016/j.earlhumdev.2004.10.017] [Cited by in Crossref: 99] [Cited by in F6Publishing: 93] [Article Influence: 5.8] [Reference Citation Analysis]
272 Iglesias J, Marik PE, Levine JS; Norasept II Study Investigators. Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock. Am J Kidney Dis 2003;41:62-75. [PMID: 12500222 DOI: 10.1053/ajkd.2003.50024] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 2.4] [Reference Citation Analysis]
273 Lisman KA, Stetson SJ, Koerner MM, Farmer JA, Torre-amione G. MANAGING HEART FAILURE WITH IMMUNOMODULATORY AGENTS. Cardiology Clinics 2001;19:617-25. [DOI: 10.1016/s0733-8651(05)70248-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
274 Bergquist M, Samuelsson L, Larsson A, Tydén J, Johansson J, Lipcsey M. TNFR1, TNFR2, neutrophil gelatinase-associated lipocalin and heparin binding protein in identifying sepsis and predicting outcome in an intensive care cohort. Sci Rep 2020;10:15350. [PMID: 32948801 DOI: 10.1038/s41598-020-72003-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
275 Espat NJ, Auffenberg T, Abouhamze A, Baumhofer J, Moldawer LL, Howard RJ. A role for tumor necrosis factor-alpha in the increased mortality associated with Vibrio vulnificus infection in the presence of hepatic dysfunction. Ann Surg 1996;223:428-33. [PMID: 8633922 DOI: 10.1097/00000658-199604000-00012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.1] [Reference Citation Analysis]
276 Liu C, Tang J. Expression levels of tumor necrosis factor-α and the corresponding receptors are correlated with trauma severity. Oncol Lett 2014;8:2747-51. [PMID: 25364459 DOI: 10.3892/ol.2014.2575] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
277 Kamihira S, Yamada Y, Tomonaga M, Sugahara K, Tsuruda K. Discrepant expression of membrane and soluble isoforms of Fas (CD95/APO-1) in adult T-cell leukaemia: soluble Fas isoform is an independent risk factor for prognosis: Fas Isoforms in ATL. British Journal of Haematology 1999;107:851-60. [DOI: 10.1046/j.1365-2141.1999.01792.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
278 Tizazu AM, Nyunt MSZ, Cexus O, Suku K, Mok E, Xian CH, Chong J, Tan C, How W, Hubert S, Combet E, Fulop T, Ng TP, Larbi A. Metformin Monotherapy Downregulates Diabetes-Associated Inflammatory Status and Impacts on Mortality. Front Physiol 2019;10:572. [PMID: 31178745 DOI: 10.3389/fphys.2019.00572] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
279 Christman JW, Holden EP, Blackwell TS. Strategies for blocking the systemic effects of cytokines in the sepsis syndrome. Crit Care Med. 1995;23:955-963. [PMID: 7736757 DOI: 10.1097/00003246-199505000-00027] [Cited by in Crossref: 66] [Cited by in F6Publishing: 50] [Article Influence: 2.4] [Reference Citation Analysis]
280 Voog E, Bienvenu J, Warzocha K, Moullet I, Dumontet C, Thieblemont C, Monneret G, Gutowski M, Coiffier B, Salles G. Factors That Predict Chemotherapy-Induced Myelosuppression in Lymphoma Patients: Role of the Tumor Necrosis Factor Ligand-Receptor System. JCO 2000;18:325-325. [DOI: 10.1200/jco.2000.18.2.325] [Cited by in Crossref: 44] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
281 Marik PE, Zaloga GP; and the Norasept II Study Investigators. The Effect of Aging on Circulating Levels of Proinflammatory Cytokines During Septic Shock. Journal of the American Geriatrics Society 2001;49:5-9. [DOI: 10.1046/j.1532-5415.2001.49003.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 2.0] [Reference Citation Analysis]
282 Wilson S, Vennervald BJ, Dunne DW. Chronic hepatosplenomegaly in African school children: a common but neglected morbidity associated with schistosomiasis and malaria. PLoS Negl Trop Dis 2011;5:e1149. [PMID: 21912707 DOI: 10.1371/journal.pntd.0001149] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
283 Herrera-garza EH, Stetson SJ, Cubillos-garzon A, Vooletich MT, Farmer JA, Torre-amione G. Tumor Necrosis Factor-α. Chest 1999;115:1170-4. [DOI: 10.1378/chest.115.4.1170] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 1.8] [Reference Citation Analysis]
284 Zhu Q, Su J, Wang X, Tang M, Gao Y, Zhang D. Serum concentrations of TNF-α and its soluble receptors in Graves' disease. Endocr Connect 2020;9:736-46. [PMID: 32621585 DOI: 10.1530/EC-20-0162] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
285 D. Heresbach, J.-p. Letourneur, I.. Value of Early Blood Th-1 Cytokine Determination in Predicting Severity of Acute Pancreatitis. Scandinavian Journal of Gastroenterology 2009;33:554-60. [DOI: 10.1080/00365529850172160] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
286 Glabinski AR, Bielecki B, Kawczak JA, Tuohy VK, Selmaj K, Ransohoff RM. Treatment with Soluble Tumor Necrosis Factor Receptor (sTNFR):Fc/p80 Fusion Protein Ameliorates Relapsing-remitting Experimental Autoimmune Encephalomyelitis and Decreases Chemokine Expression. Autoimmunity 2009;37:465-71. [DOI: 10.1080/08916930400001859] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
287 Kogo J, Takeba Y, Kumai T, Kitaoka Y, Matsumoto N, Ueno S, Kobayashi S. Involvement of TNF-alpha in glutamate-induced apoptosis in a differentiated neuronal cell line. Brain Res 2006;1122:201-8. [PMID: 17046730 DOI: 10.1016/j.brainres.2006.09.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
288 Ing SW, Orchard TS, Lu B, LaMonte MJ, Barbour KE, Cauley JA, Jackson RD. TNF Receptors Predict Hip Fracture Risk in the WHI Study and Fatty Acid Intake Does Not Modify This Association. J Clin Endocrinol Metab 2015;100:3380-7. [PMID: 26161450 DOI: 10.1210/JC.2015-1662] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
289 Mackay SL, Tannahill CL, Auffenberg T, Ksontini R, Copeland EM, Moldawer LL. Characterization in Vitro and in Vivo of Hammerhead Ribozymes Directed against Murine Tumor Necrosis Factorα. Biochemical and Biophysical Research Communications 1999;260:390-7. [DOI: 10.1006/bbrc.1999.0927] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
290 Heney D, Whicher JT. Factors affecting the measurement of cytokines in biological fluids: implications for their clinical measurement. Ann Clin Biochem 1995;32 ( Pt 4):358-68. [PMID: 7486794 DOI: 10.1177/000456329503200402] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 1.5] [Reference Citation Analysis]
291 Cooney R, Kimball SR, Eckman R, Maish G, Shumate M, Vary TC. TNF-binding protein ameliorates inhibition of skeletal muscle protein synthesis during sepsis. American Journal of Physiology-Endocrinology and Metabolism 1999;276:E611-9. [DOI: 10.1152/ajpendo.1999.276.4.e611] [Cited by in Crossref: 30] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
292 Poll T, Deventer SJH. Endotoxemia in Healthy Subjects as a Human Model of Inflammation. In: Marshall JC, Cohen J, editors. Immune Response in the Critically Ill. Berlin: Springer Berlin Heidelberg; 2000. pp. 335-57. [DOI: 10.1007/978-3-642-57210-4_22] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
293 Zhang L, Higuchi M, Totpal K, Chaturvedi M, Aggarwal B. Staurosporine induces the cell surface expression of both forms of human tumor necrosis factor receptors on myeloid and epithelial cells and modulates ligand-induced cellular response. Journal of Biological Chemistry 1994;269:10270-9. [DOI: 10.1016/s0021-9258(17)34057-7] [Cited by in Crossref: 12] [Article Influence: 0.4] [Reference Citation Analysis]
294 Ossege LM, Sindern E, Patzold T, Malin JP. Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosis. Int Immunopharmacol 2001;1:1085-100. [PMID: 11407304 DOI: 10.1016/s1567-5769(01)00039-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
295 Clarke DJ, Branton RL. A role for tumor necrosis factor alpha in death of dopaminergic neurons following neural transplantation. Exp Neurol 2002;176:154-62. [PMID: 12093092 DOI: 10.1006/exnr.2002.7911] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 1.7] [Reference Citation Analysis]
296 Hoffmann U, Bergler T, Rihm M, Pace C, Krüger B, Rümmele P, Stoelcker B, Banas B, Männel DN, Krämer BK. Upregulation of TNF Receptor Type 2 in Human and Experimental Renal Allograft Rejection. American Journal of Transplantation 2009;9:675-86. [DOI: 10.1111/j.1600-6143.2008.02536.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
297 Trüeb RM. Rheumatic Disease Group. In: Burg G, Dummer RG, editors. Strategies for Immunointerventions in Dermatology. Berlin: Springer Berlin Heidelberg; 1997. pp. 227-41. [DOI: 10.1007/978-3-642-60752-3_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
298 Adamopoulos S, Parissis JT, Kremastinos DT. A glossary of circulating cytokines in chronic heart failure. European Journal of Heart Failure 2001;3:517-26. [DOI: 10.1016/s1388-9842(01)00156-8] [Cited by in Crossref: 88] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
299 Weerwind P, Maessen J, van Tits L, Stad R, Fransen E, de Jong D, Penn O. Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypass. The Journal of Thoracic and Cardiovascular Surgery 1995;110:1633-41. [DOI: 10.1016/s0022-5223(95)70024-2] [Cited by in Crossref: 63] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
300 Van Zee KJ, Stackpole SA, Montegut WJ, Rogy MA, Calvano SE, Hsu KC, Chao M, Meschter CL, Loetscher H, Stüber D. A human tumor necrosis factor (TNF) alpha mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon. J Exp Med 1994;179:1185-91. [PMID: 8145037 DOI: 10.1084/jem.179.4.1185] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 1.9] [Reference Citation Analysis]
301 Lowry SF. HUMAN ENDOTOXEMIA: A MODEL FOR MECHANISTIC INSIGHT AND THERAPEUTIC TARGETING. Shock 2005;24:94-100. [DOI: 10.1097/01.shk.0000191340.23907.a1] [Cited by in Crossref: 113] [Cited by in F6Publishing: 108] [Article Influence: 6.6] [Reference Citation Analysis]
302 Gustot T, Lemmers A, Louis E, Nicaise C, Quertinmont E, Belaiche J, Roland S, Van Gossum A, Devière J, Franchimont D. Profile of soluble cytokine receptors in Crohn's disease. Gut 2005;54:488-95. [PMID: 15753533 DOI: 10.1136/gut.2004.043554] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 3.1] [Reference Citation Analysis]
303 Rigato O, Ujvari S, Castelo A, Salomão R. Tumor necrosis factor alpha (TNF-α) and sepsis: Evidence for a role in host defense. Infection 1996;24:314-8. [DOI: 10.1007/bf01743367] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
304 Dinarello CA. Cytokines as mediators in the pathogenesis of septic shock. Curr Top Microbiol Immunol 1996;216:133-65. [PMID: 8791739 DOI: 10.1007/978-3-642-80186-0_7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 52] [Article Influence: 1.0] [Reference Citation Analysis]
305 Milano S, Arcoleo F, D'Agostino P, Cillari E. Intraperitoneal injection of tetracyclines protects mice from lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood. Antimicrob Agents Chemother 1997;41:117-21. [PMID: 8980766 DOI: 10.1128/AAC.41.1.117] [Cited by in Crossref: 59] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
306 Doellner H, Arntzen KJ, Haereid PE, Aag S, Brubakk A, Austgulen R. Increased serum concentrations of soluble tumor necrosis factor receptors p55 and p75 in early onset neonatal sepsis. Early Human Development 1998;52:251-61. [DOI: 10.1016/s0378-3782(98)00031-0] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
307 Oliveira JG, Xavier P, Sampaio SM, Mendes AA, Pestana M. sTNFRI AND sTNFRII SYNTHESIS BY FINE-NEEDLE ASPIRATION BIOPSY SAMPLE CULTURES IS SIGNIFICANTLY ASSOCIATED WITH ACUTE REJECTION IN KIDNEY TRANSPLANTATION1: . Transplantation 2001;71:1835-9. [DOI: 10.1097/00007890-200106270-00021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
308 Payne-Emerson H, Lennie TA. Nutritional considerations in heart failure. Nurs Clin North Am 2008;43:117-32; vii. [PMID: 18249228 DOI: 10.1016/j.cnur.2007.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
309 Rosenberg JJ, Martin SW, Seely JE, Kinstler O, Gaines GC, Fukuzuka K, Rose J, Kohno T, Boyle WJ, Nelson A, Kieft GL, Marshall WS, Feige U, Gasser J, St. Clair J, Frazier J, Abouhamze A, Moldawer LL, Edwards CK. Development of a novel, nonimmunogenic, soluble human TNF receptor type I (sTNFR-I) construct in the baboon. Journal of Applied Physiology 2001;91:2213-23. [DOI: 10.1152/jappl.2001.91.5.2213] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
310 Bouhlal H, Kaveri S. Multi-faceted role of naturally occurring autoantibodies in fighting pathogens. Adv Exp Med Biol 2012;750:100-13. [PMID: 22903669 DOI: 10.1007/978-1-4614-3461-0_8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
311 Azevedo ZM, Luz RA, Victal SH, Kurdian B, Fonseca VM, Fitting C, Câmara FP, Haeffner-Cavaillon N, Cavaillon JM, Gaspar Elsas MI, Xavier Elsas P. Increased production of tumor necrosis factor-alpha in whole blood cultures from children with primary malnutrition. Braz J Med Biol Res 2005;38:171-83. [PMID: 15785828 DOI: 10.1590/s0100-879x2005000200005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
312 Engel A, Kern WV, Mürdter G, Kern P. Kinetics and correlation with body temperature of circulating interleukin-6, interleukin-8, tumor necrosis factor alpha and interleukin-1 beta in patients with fever and neutropenia. Infection 1994;22:160-4. [DOI: 10.1007/bf01716695] [Cited by in Crossref: 24] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
313 Orlando S, Sironi M, Bianchi G, Drummond AH, Boraschi D, Yabes D, Mantovani A. Role of Metalloproteases in the Release of the IL-1 type II Decoy Receptor. Journal of Biological Chemistry 1997;272:31764-9. [DOI: 10.1074/jbc.272.50.31764] [Cited by in Crossref: 83] [Cited by in F6Publishing: 78] [Article Influence: 3.3] [Reference Citation Analysis]
314 Dionne S, D'Agata ID, Hiscott J, Vanounou T, Seidman EG. Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD). Clin Exp Immunol. 1998;112:435-442. [PMID: 9649212 DOI: 10.1046/j.1365-2249.1998.00595.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 2.6] [Reference Citation Analysis]
315 Lowe PR, Galley HF, Abdel-fattah A, Webster NR. Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients*: . Critical Care Medicine 2003;31:34-8. [DOI: 10.1097/00003246-200301000-00005] [Cited by in Crossref: 106] [Cited by in F6Publishing: 91] [Article Influence: 5.6] [Reference Citation Analysis]
316 Millan MT, Geczy C, Stuhlmeier KM, Goodman DJ, Ferran C, Bach FH. HUMAN MONOCYTES ACTIVATE PORCINE ENDOTHELIAL CELLS, RESULTING IN INCREASED E-SELECTIN, INTERLEUKIN-8, MONOCYTE CHEMOTACTIC PROTEIN-1, AND PLASMINOGEN ACTIVATOR INHIBITOR-TYPE-1 EXPRESSION1: . Transplantation 1997;63:421-9. [DOI: 10.1097/00007890-199702150-00016] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 2.3] [Reference Citation Analysis]
317 Kimura F, Miyazaki M, Suwa T, Sugiura T, Shinoda T, Itoh H, Ambiru S, Shimizu H, Nakagawa K. Plasma concentration of cytokine antagonists in patients with infection following liver resection. Br J Surg 1998;85:1631-5. [PMID: 9876064 DOI: 10.1046/j.1365-2168.1998.00949.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
318 Kaech C, Bochud P, Calandra T, Donnenberg MS. Cytokines and Escherichia coli Sepsis. EcoSal Plus 2006;2. [DOI: 10.1128/ecosalplus.8.8.15] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
319 Malleo G, Mazzon E, Genovese T, Di Paola R, Muià C, Centorrino T, Siriwardena AK, Cuzzocrea S. Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice: a comparison with TNF-alpha genetic deletion. Shock. 2007;27:542-551. [PMID: 17438460 DOI: 10.1097/01.shk.0000246900.50445.1d] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 2.0] [Reference Citation Analysis]
320 Realdon S, Pontisso P, Adami F, Trentin L, Noventa F, Ferrari A, Migliorato I, Gatta A, Alberti A. High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders. Journal of Hepatology 2001;34:723-9. [DOI: 10.1016/s0168-8278(00)00063-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
321 Lowry SF, Moldawer LL, Calvano SE. Cytokine Markers of the Human Response to Sepsis. In: Vincent J, editor. Yearbook of Intensive Care and Emergency Medicine 1994. Berlin: Springer Berlin Heidelberg; 1994. pp. 14-23. [DOI: 10.1007/978-3-642-85068-4_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
322 Rumalla VK, Calvano SE, Spotnitz AJ, Krause TJ, Hilkert RJ, Lin E, Lowry SF. Alterations in immunocyte tumor necrosis factor receptor and apoptosis in patients with congestive heart failure. Ann Surg 2002;236:254-60. [PMID: 12170032 DOI: 10.1097/00000658-200208000-00015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
323 Smit PJ, Guo WA, Davidson BA, Mullan BA, Helinski JD, Knight PR 3rd. Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury. J Surg Res 2014;191:214-23. [PMID: 24814199 DOI: 10.1016/j.jss.2014.04.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
324 Schenk JM, Kristal AR, Neuhouser ML, Tangen CM, White E, Lin DW, Kratz M, Thompson IM. Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol 2010;171:571-82. [PMID: 20142396 DOI: 10.1093/aje/kwp406] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 5.8] [Reference Citation Analysis]
325 Partrick DA, Moore EE, Moore FA, Biffl WL, Barnett CC. Release of anti-inflammatory mediators after major torso trauma correlates with the development of postinjury multiple organ failure. The American Journal of Surgery 1999;178:564-8. [DOI: 10.1016/s0002-9610(99)00240-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
326 Torres DJL, Arruda TR, Barros MDS, Gonçales JP, Soares AKA, Oliveira KKDS, Moreira LR, Medeiros C, Cavalcanti MDGAM, Martins SM, Carrazzone C, Oliveira W, Lannes-Vieira J, Lorena VMB. Is a negative correlation between sTNFR1 and TNF in patients with chronic Chagas disease the key to clinical progression? Immunobiology 2021;227:152166. [PMID: 34936965 DOI: 10.1016/j.imbio.2021.152166] [Reference Citation Analysis]
327 Rogy MA, Beinhauer BG, Fang M. [Liposome mediated gene transfer - the future therapy for sepsis and intraabdominal infection?]. Acta Chir Austriaca 2000;32:179-84. [PMID: 32287332 DOI: 10.1007/BF02949260] [Reference Citation Analysis]
328 Sakimoto T, Yamada A, Kanno H, Sawa M. Upregulation of tumor necrosis factor receptor 1 and TNF-alpha converting enzyme during corneal wound healing. Jpn J Ophthalmol 2008;52:393-8. [PMID: 18991041 DOI: 10.1007/s10384-008-0536-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
329 Díaz-castro J, Guisado R, Kajarabille N, García C, Guisado IM, de Teresa C, Ochoa JJ. Coenzyme Q10 supplementation ameliorates inflammatory signaling and oxidative stress associated with strenuous exercise. Eur J Nutr 2012;51:791-9. [DOI: 10.1007/s00394-011-0257-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
330 Leon LR, Dineen S, Blaha MD, Rodriguez-fernandez M, Clarke DC. Attenuated thermoregulatory, metabolic, and liver acute phase protein response to heat stroke in TNF receptor knockout mice. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2013;305:R1421-32. [DOI: 10.1152/ajpregu.00127.2013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
331 Langmann GA, Perera S, Ferchak MA, Nace DA, Resnick NM, Greenspan SL. Inflammatory Markers and Frailty in Long-Term Care Residents. J Am Geriatr Soc 2017;65:1777-83. [PMID: 28323342 DOI: 10.1111/jgs.14876] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
332 Sanchez SE, Zhang C, Williams MA, Ware-Jauregui S, Larrabure G, Bazul V, Farrand A. Tumor necrosis factor-alpha soluble receptor p55 (sTNFp55) and risk of preeclampsia in Peruvian women. J Reprod Immunol 2000;47:49-63. [PMID: 10779590 DOI: 10.1016/s0165-0378(99)00064-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
333 Yan J, Zhang H, Xiang J, Zhao Y, Yuan X, Sun B, Lin A. The BH3-only protein BAD mediates TNFα cytotoxicity despite concurrent activation of IKK and NF-κB in septic shock. Cell Res 2018;28:701-18. [PMID: 29795446 DOI: 10.1038/s41422-018-0041-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
334 Dinarello CA. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest. 1997;112:321S-329S. [PMID: 9400897 DOI: 10.1378/chest.112.6_Supplement.321S] [Cited by in Crossref: 322] [Cited by in F6Publishing: 117] [Article Influence: 12.9] [Reference Citation Analysis]
335 Gesta S, Kahn CR. White Adipose Tissue. In: Symonds ME, editor. Adipose Tissue Biology. New York: Springer; 2012. pp. 71-121. [DOI: 10.1007/978-1-4614-0965-6_4] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
336 Naume B, Johnsen AC, Espevik T, Sundan A. Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56+ natural killer cells stimulated with interleukin-2, interleukin-7 and interleukin-12. Eur J Immunol 1993;23:1831-8. [PMID: 7688307 DOI: 10.1002/eji.1830230815] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 1.9] [Reference Citation Analysis]
337 Ralston DR, St John RC. IMMUNOTHERAPY FOR SEPSIS. Clinics in Chest Medicine 1996;17:307-17. [DOI: 10.1016/s0272-5231(05)70316-6] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
338 Díaz-Castro J, Florido J, Kajarabille N, Prados S, de Paco C, Ocon O, Pulido-Moran M, Ochoa JJ. A new approach to oxidative stress and inflammatory signaling during labour in healthy mothers and neonates. Oxid Med Cell Longev 2015;2015:178536. [PMID: 25722791 DOI: 10.1155/2015/178536] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
339 Westacott CI, Barakat AF, Wood L, Perry MJ, Neison P, Bisbinas I, Armstrong L, Millar AB, Elson CJ. Tumor necrosis factor alpha can contribute to focal loss of cartilage in osteoarthritis. Osteoarthritis Cartilage 2000;8:213-21. [PMID: 10806049 DOI: 10.1053/joca.1999.0292] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 2.7] [Reference Citation Analysis]
340 Hasegawa M, Nishii C, Kabutan N, Kato M, Ohashi A, Nakai S, Murakami K, Tomita M, Nabeshima K, Hiki Y, Oshima H, Sugiyama S. Effects of Cytapheresis on Tumor Necrosis Factor Receptor and on Expression of CD63 in Myeloperoxidase?Antineutrophil Cytoplasmic Autoantibody-associated Vasculitis. Therapher Dial 2007;11:337-40. [DOI: 10.1111/j.1744-9987.2007.00496.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
341 Frühbeck G, Gómez-Ambrosi J, Muruzábal FJ, Burrell MA. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 2001;280:E827-47. [PMID: 11350765 DOI: 10.1152/ajpendo.2001.280.6.E827] [Cited by in Crossref: 503] [Cited by in F6Publishing: 166] [Article Influence: 24.0] [Reference Citation Analysis]
342 Hashim IA, Al-Zeer A, Al-Shohaib S, Al-Ahwal M, Shenkin A. Cytokine changes in patients with heatstroke during pilgrimage to Makkah. Mediators Inflamm. 1997;6:135-139. [PMID: 18472847 DOI: 10.1080/09629359791839] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
343 Rodriguez-Ramos C, Galan F, Diaz F, Elvira J, Martin-Herrera L, Giron-Gonzalez JA. Expression of proinflammatory cytokines and gheir inhibitors during the course of spontaneous bacterial peritonitis. Dig Dis Sci. 2001;46:1668-1676. [PMID: 11508666 DOI: 10.1023/a:1010645302750] [Cited by in Crossref: 35] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
344 Schaap LA, Pluijm SM, Deeg DJ, Harris TB, Kritchevsky SB, Newman AB, Colbert LH, Pahor M, Rubin SM, Tylavsky FA, Visser M; Health ABC Study. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 2009;64:1183-9. [PMID: 19622801 DOI: 10.1093/gerona/glp097] [Cited by in Crossref: 359] [Cited by in F6Publishing: 349] [Article Influence: 27.6] [Reference Citation Analysis]
345 Palladino MA, Bahjat FR, Theodorakis EA, Moldawer LL. Anti-TNF-alpha therapies: the next generation. Nat Rev Drug Discov. 2003;2:736-746. [PMID: 12951580 DOI: 10.1038/nrd1175] [Cited by in Crossref: 403] [Cited by in F6Publishing: 365] [Article Influence: 21.2] [Reference Citation Analysis]
346 Parks RW, Gardiner KR, Halliday MI, Rowlands BJ. Soluble TNF receptors as prognostic factors for mortality. Gut 1997;40:560. [PMID: 9176093 DOI: 10.1136/gut.40.4.560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
347 Zylberberg H, Rimaniol AC, Pol S, Masson A, De Groote D, Berthelot P, Bach JF, Bréchot C, Zavala F. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity. J Hepatol. 1999;30:185-191. [PMID: 10068094 DOI: 10.1016/s0168-8278(99)80060-9] [Cited by in Crossref: 133] [Cited by in F6Publishing: 35] [Article Influence: 5.8] [Reference Citation Analysis]
348 Spahr L, Giostra E, Frossard JL, Bresson-Hadni S, Rubbia-Brandt L, Hadengue A. Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis. J Hepatol. 2004;41:229-234. [PMID: 15288471 DOI: 10.1016/j.jhep.2004.04.028] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
349 Zhai R, Liu G, Ge X, Bao W, Wu C, Yang C, Liang D. Serum levels of tumor necrosis factor-α (TNF-α), interleukin 6 (IL-6), and their soluble receptors in coal workers' pneumoconiosis. Respiratory Medicine 2002;96:829-34. [DOI: 10.1053/rmed.2002.1367] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
350 Rogy MA, Auffenberg T, Espat NJ, Philip R, Remick D, Wollenberg GK, Copeland EM 3rd, Moldawer LL. Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses. J Exp Med 1995;181:2289-93. [PMID: 7760015 DOI: 10.1084/jem.181.6.2289] [Cited by in Crossref: 77] [Cited by in F6Publishing: 64] [Article Influence: 2.9] [Reference Citation Analysis]
351 Edwards CK 3rd. PEGylated recombinant human soluble tumour necrosis factor receptor type I (r-Hu-sTNF-RI): novel high affinity TNF receptor designed for chronic inflammatory diseases. Ann Rheum Dis 1999;58 Suppl 1:I73-81. [PMID: 10577978 DOI: 10.1136/ard.58.2008.i73] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 2.4] [Reference Citation Analysis]
352 Wu S, Korte A, Gessner R, Henze G, Seeger K. Levels of the soluble, 55-kilodalton isoform of tumor necrosis factor receptor in bone marrow are correlated with the clinical outcome of children with acute lymphoblastic leukemia in first recurrence. Cancer 2003;98:625-31. [DOI: 10.1002/cncr.11553] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
353 Hammami MM, Bouchama A, Al-Sedairy S, Shail E, AlOhaly Y, Mohamed GE. Concentrations of soluble tumor necrosis factor and interleukin-6 receptors in heatstroke and heatstress. Crit Care Med 1997;25:1314-9. [PMID: 9267943 DOI: 10.1097/00003246-199708000-00017] [Cited by in Crossref: 101] [Cited by in F6Publishing: 82] [Article Influence: 4.0] [Reference Citation Analysis]
354 Baxter RC. Chapter 5 Molecular aspects of insulin-like growth factor binding proteins. Elsevier; 1997. pp. 123-59. [DOI: 10.1016/s1569-2566(97)80036-1] [Cited by in Crossref: 17] [Article Influence: 0.7] [Reference Citation Analysis]
355 Robak E, Sysa-Jedrzejowska A, Robak T, Stepień H, Woźniacka A, Waszczykowsk E. Tumour necrosis factor alpha (TNF-alpha), interleukin-6 (IL-6) and their soluble receptors (sTNF-alpha-Rp55 and slL-6R) serum levels in systemic lupus erythematodes. Mediators Inflamm 1996;5:435-41. [PMID: 18475749 DOI: 10.1155/S0962935196000609] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
356 Malleo G, Mazzon E, Genovese T, Paola RD, Muià C, Caminiti R, Esposito E, Bella PD, Cuzzocrea S. ETANERCEPT REDUCES ACUTE TISSUE INJURY AND MORTALITY ASSOCIATED TO ZYMOSAN-INDUCED MULTIPLE ORGAN DYSFUNCTION SYNDROME. Shock 2008;29:560-71. [DOI: 10.1097/shk.0b013e3181507234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
357 Moysidis SN, Thanos A, Vavvas DG. Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside. Mediators Inflamm 2012;2012:815937. [PMID: 23049173 DOI: 10.1155/2012/815937] [Cited by in Crossref: 55] [Cited by in F6Publishing: 61] [Article Influence: 5.5] [Reference Citation Analysis]
358 Kimberley FC, Lobito AA, Siegel RM, Screaton GR. Falling into TRAPS--receptor misfolding in the TNF receptor 1-associated periodic fever syndrome. Arthritis Res Ther 2007;9:217. [PMID: 17666110 DOI: 10.1186/ar2197] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
359 van Meijl LEC, Mensink RP. Effects of low-fat dairy consumption on markers of low-grade systemic inflammation and endothelial function in overweight and obese subjects: an intervention study. Br J Nutr 2010;104:1523-7. [DOI: 10.1017/s0007114510002515] [Cited by in Crossref: 49] [Cited by in F6Publishing: 18] [Article Influence: 4.1] [Reference Citation Analysis]
360 van der Poll T, Keogh C, Helfgott D, Berman L, Buurman W, Lowry S. Effects of anti-interleukin 6 on inflammatory responses during murine septic peritonitis. Journal of Endotoxin Research 1996;3:463-70. [DOI: 10.1177/096805199600300604] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
361 Brandtzaeg P. Significance and pathogenesis of septic shock. Curr Top Microbiol Immunol 1996;216:15-37. [PMID: 8791734 DOI: 10.1007/978-3-642-80186-0_2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
362 Duna GF, Galperin C, Hoffman GS. WEGENER'S GRANULOMATOSIS. Rheumatic Disease Clinics of North America 1995;21:949-86. [DOI: 10.1016/s0889-857x(21)00480-4] [Cited by in Crossref: 28] [Article Influence: 1.0] [Reference Citation Analysis]
363 Zentner A, Rendl J, Grelle I, Dummer R, Br�cker EB, Zillikens D. Elevated levels of soluble tumour necrosis factor receptor I in blister fluids of bullous pemphigoid and suction blisters. Arch Dermatol Res 1994;286:355-7. [DOI: 10.1007/bf00402229] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
364 Shibata J, Goto H, Arisawa T, Niwa Y, Hayakawa T, Nakayama A, Mori N. Regulation of tumour necrosis factor (TNF) induced apoptosis by soluble TNF receptors in Helicobacter pylori infection. Gut. 1999;45:24-31. [PMID: 10369700 DOI: 10.1136/gut.45.1.24] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.4] [Reference Citation Analysis]
365 Backonja MM, Coe CL, Muller DA, Schell K. Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients. J Neuroimmunol 2008;195:157-63. [PMID: 18325600 DOI: 10.1016/j.jneuroim.2008.01.005] [Cited by in Crossref: 92] [Cited by in F6Publishing: 88] [Article Influence: 6.6] [Reference Citation Analysis]
366 Leiderman YI, Miller JW. Proliferative vitreoretinopathy: pathobiology and therapeutic targets. Semin Ophthalmol 2009;24:62-9. [PMID: 19373688 DOI: 10.1080/08820530902800082] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
367 Efron PA, Tinsley K, Minnich DJ, Monterroso V, Wagner J, Lainée P, Lorré K, Swanson PE, Hotchkiss R, Moldawer LL. Increased lymphoid tissue apoptosis in baboons with bacteremic shock. Shock 2004;21:566-71. [PMID: 15167687 DOI: 10.1097/01.shk.0000126648.58732.8c] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
368 Ermert M, Pantazis C, Duncker H, Grimminger F, Seeger W, Ermert L. In situ localization of TNFα/β, TACE AND TNF receptors TNF-R1 and TNF-R2 in control and LPS-treated lung tissue. Cytokine 2003;22:89-100. [DOI: 10.1016/s1043-4666(03)00117-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
369 Steinshamn S, Brekke O, Waage A. Soluble tumour necrosis factor receptors, tumour necrosis factor and interleukin-6 in serum in granulocytopenic patients with fever. British Journal of Haematology 1995;89:719-24. [DOI: 10.1111/j.1365-2141.1995.tb08407.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
370 Abraham E. Clinical Sepsis Trials. Chest 1994;105:53S-5S. [DOI: 10.1378/chest.105.3_supplement.53s] [Cited by in Crossref: 4] [Article Influence: 0.1] [Reference Citation Analysis]
371 Hebert JC, O’reilly M, Bednar MM. Modifying the Host Response to Injury: The Future of Trauma Care. Surgical Clinics of North America 1995;75:335-49. [DOI: 10.1016/s0039-6109(16)46592-8] [Cited by in Crossref: 11] [Article Influence: 0.4] [Reference Citation Analysis]
372 Ryan LA, Brester M, Bohac D, Morgello S, Zheng J. Up-regulation of soluble tumor necrosis factor receptor two in plasma of HIV-seropositive individuals who use opiates. AIDS Res Hum Retroviruses 2004;20:41-5. [PMID: 15000697 DOI: 10.1089/088922204322749486] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
373 Hayes KS, Bancroft AJ, Grencis RK. The role of TNF-alpha in Trichuris muris infection I: influence of TNF-alpha receptor usage, gender and IL-13. Parasite Immunol 2007;29:575-82. [PMID: 17944747 DOI: 10.1111/j.1365-3024.2007.00979.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
374 Redl H, Schlag G, Adolf GR, Natmessnig B, Davies J. Tumor necrosis factor (TNF)-dependent shedding of the p55 TNF receptor in a baboon model of bacteremia. Infect Immun 1995;63:297-300. [DOI: 10.1128/iai.63.1.297-300.1995] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
375 Wang J, Al-lamki RS, Zhang H, Kirkiles-smith N, Gaeta ML, Thiru S, Pober JS, Bradley JR. Histamine Antagonizes Tumor Necrosis Factor (TNF) Signaling by Stimulating TNF Receptor Shedding from the Cell Surface and Golgi Storage Pool. Journal of Biological Chemistry 2003;278:21751-60. [DOI: 10.1074/jbc.m212662200] [Cited by in Crossref: 66] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
376 O'Callaghan DJ, O'Dea KP, Scott AJ, Takata M, Gordon AC. Monocyte Tumor Necrosis Factor-α-Converting Enzyme Catalytic Activity and Substrate Shedding in Sepsis and Noninfectious Systemic Inflammation. Crit Care Med 2015;43:1375-85. [PMID: 25867908 DOI: 10.1097/CCM.0000000000000992] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
377 Hack CE, Aarden LA, Thijs LG. Role of cytokines in sepsis. Adv Immunol 1997;66:101-95. [PMID: 9328641 DOI: 10.1016/s0065-2776(08)60597-0] [Cited by in Crossref: 196] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]
378 Aboab J, Nardi O, Lipiner D, Sharshar T, Annane D. Emerging drugs for the treatment of sepsis. Expert Opin Emerg Drugs 2006;11:7-22. [PMID: 16503823 DOI: 10.1517/14728214.11.1.7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
379 Wei W, Wang X, Huang Z, Li X, Luo Y. Difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary artery ectasia. J Thorac Dis 2020;12:5811-21. [PMID: 33209413 DOI: 10.21037/jtd-20-1579] [Reference Citation Analysis]
380 Sietses C, Wiezer MJ, Eijsbouts QA, Beelen RH, van Leeuwen PA, von Blomberg BM, Meijer S, Cuesta MA. A prospective randomized study of the systemic immune response after laparoscopic and conventional Nissen fundoplication. Surgery. 1999;126:5-9. [PMID: 10418585 DOI: 10.1067/msy.1999.98702] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 2.7] [Reference Citation Analysis]
381 Wang Y, Che M, Xin J, Zheng Z, Li J, Zhang S. The role of IL-1β and TNF-α in intervertebral disc degeneration. Biomed Pharmacother 2020;131:110660. [PMID: 32853910 DOI: 10.1016/j.biopha.2020.110660] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 12.5] [Reference Citation Analysis]
382 Weaver-Mikaere L, Gibbons HM, De Silva D, Fraser M. Primary mixed glial cultures from fetal ovine forebrain are a valid model of inflammation-mediated white matter injury. Dev Neurosci 2012;34:30-42. [PMID: 22627272 DOI: 10.1159/000338039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
383 Gohda T, Tomino Y. Novel biomarkers for the progression of diabetic nephropathy: soluble TNF receptors. Curr Diab Rep 2013;13:560-6. [PMID: 23657763 DOI: 10.1007/s11892-013-0385-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
384 Baud L, Fouqueray B, Bellocq A. Switching off renal inflammation by anti-inflammatory mediators: The facts, the promise and the hope. Kidney International 1998;53:1118-26. [DOI: 10.1046/j.1523-1755.1998.00877.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
385 Schröder J, Stüber F, Gallati H, Schade FU, Kremer B. Pattern of soluble TNF receptors I and II in sepsis. Infection 1995;23:143-8. [PMID: 7499002 DOI: 10.1007/BF01793854] [Cited by in Crossref: 47] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
386 Tilg H, Vogel W, Wiedermann CJ, Shapiro L, Herold M, Judmaier G, Dinarello CA. Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease. Hepatology 1993;18:1132-8. [DOI: 10.1002/hep.1840180519] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 1.7] [Reference Citation Analysis]
387 Eichacker PQ, Parent C, Kalil A, Esposito C, Cui X, Banks SM, Gerstenberger EP, Fitz Y, Danner RL, Natanson C. Risk and the Efficacy of Antiinflammatory Agents: Retrospective and Confirmatory Studies of Sepsis. Am J Respir Crit Care Med 2002;166:1197-205. [DOI: 10.1164/rccm.200204-302oc] [Cited by in Crossref: 263] [Cited by in F6Publishing: 87] [Article Influence: 13.2] [Reference Citation Analysis]
388 Hall RI, Smith MS, Rocker G. The Systemic Inflammatory Response to Cardiopulmonary Bypass: Pathophysiological, Therapeutic, and Pharmacological Considerations. Anesthesia & Analgesia 1997;85:766-82. [DOI: 10.1213/00000539-199710000-00011] [Cited by in Crossref: 230] [Cited by in F6Publishing: 166] [Article Influence: 9.2] [Reference Citation Analysis]
389 Selmaj K, Walczak A, Mycko M, Berkowicz T, Kohno T, Raine CS. Suppression of experimental autoimmune encephalomyelitis with a TNF binding protein (TNFbp) correlates with down-regulation of VCAM-1/VLA-4. Eur J Immunol 1998;28:2035-44. [DOI: 10.1002/(sici)1521-4141(199806)28:06<2035::aid-immu2035>3.0.co;2-a] [Cited by in Crossref: 28] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
390 Pessayre D, Feldmann G, Haouzi D, Fau D, Moreau A, Neuman M. Hepatocyte Apoptosis Triggered by Natural Substances (Cytokines, Other Endogenous Molecules and Foreign Toxins). In: Cameron RG, Feuer G, editors. Apoptosis and Its Modulation by Drugs. Berlin: Springer Berlin Heidelberg; 2000. pp. 59-108. [DOI: 10.1007/978-3-642-57075-9_3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
391 von Baehr V, Döcke WD, Plauth M, Liebenthal C, Küpferling S, Lochs H, Baumgarten R, Volk HD. Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation. Gut. 2000;47:281-287. [PMID: 10896923 DOI: 10.1136/gut.47.2.281] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 2.3] [Reference Citation Analysis]
392 Liu DF, Wei W, Song LH. Protective effect of paeoniflorin on immunological liver injury induced by bacillus Calmette-Guerin plus lipopolysaccharide: modulation of tumour necrosis factor-alpha and interleukin-6 MRNA. Clin Exp Pharmacol Physiol 2006;33:332-9. [PMID: 16620297 DOI: 10.1111/j.1440-1681.2006.04371.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 3.3] [Reference Citation Analysis]
393 Porat R, Paddock H, Cominelli F, Marra M, Scott R, Schwaitzberg S, Dinarello C. Effects of bactericidal/permeability-increasing protein on endotoxin-induced fever and Escherichia coli-induced shock in rabbits. Journal of Endotoxin Research 1995;2:9-18. [DOI: 10.1177/096805199500200102] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
394 Szondy Z, Pallai A. Transmembrane TNF-alpha reverse signaling leading to TGF-beta production is selectively activated by TNF targeting molecules: Therapeutic implications. Pharmacological Research 2017;115:124-32. [DOI: 10.1016/j.phrs.2016.11.025] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
395 Lawlor D, Brock RW, Harris KA, Potter RF. Cytokines contribute to early hepatic parenchymal injury and microvascular dysfunction after bilateral hindlimb ischemia. Journal of Vascular Surgery 1999;30:533-41. [DOI: 10.1016/s0741-5214(99)70081-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
396 Hall RI, Smith MS, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 1997;85:766-82. [PMID: 9322454 DOI: 10.1097/00000539-199710000-00011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 50] [Article Influence: 0.8] [Reference Citation Analysis]
397 Mwangi SM, Stabel J, Lee E, Kehrli ME, Taylor MJ. Expression and characterization of a recombinant soluble form of bovine tumor necrosis factor receptor type I. Veterinary Immunology and Immunopathology 2000;77:233-41. [DOI: 10.1016/s0165-2427(00)00244-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
398 Ossege L, Sindern E, Patzold T, Malin J. Immunomodulatory effects of interferon-β-1b in vivo: induction of the expression of transforming growth factor-β1 and its receptor type II. Journal of Neuroimmunology 1998;91:73-81. [DOI: 10.1016/s0165-5728(98)00154-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
399 Fukata J, Imura H, Nakao K. Cytokines as mediators in the regulation of the hypothalamic-pituitary-adrenocortical function. J Endocrinol Invest 1994;17:141-55. [DOI: 10.1007/bf03347705] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
400 Perucci LO, Gomes KB, Freitas LG, Godoi LC, Alpoim PN, Pinheiro MB, Miranda AS, Teixeira AL, Dusse LM, Sousa LP. Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia. PLoS One 2014;9:e97632. [PMID: 24851923 DOI: 10.1371/journal.pone.0097632] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
401 Ho GY, Wang T, Zheng SL, Tinker L, Xu J, Rohan TE, Wassertheil-Smoller S, Xue X, Augenlicht LH, Peters U, Phipps AI, Strickler HD, Gunter MJ, Cushman M. Circulating soluble cytokine receptors and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2014;23:179-188. [PMID: 24192010 DOI: 10.1158/1055-9965.epi-13-0545] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
402 Wang M, Meng X, Tsai B, Wang J, Turrentine M, Brown JW, Meldrum DR. Preconditioning up-regulates the soluble TNF receptor I response to endotoxin. Journal of Surgical Research 2004;121:20-4. [DOI: 10.1016/j.jss.2004.02.017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
403 Meng X, Ao L, Brown JM, Meldrum DR, Sheridan BC, Cain BS, Banerjee A, Harken AH. LPS induces late cardiac functional protection against ischemia independent of cardiac and circulating TNF-alpha. Am J Physiol 1997;273:H1894-902. [PMID: 9362258 DOI: 10.1152/ajpheart.1997.273.4.H1894] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 0.4] [Reference Citation Analysis]
404 Rivera S, Sattler FR, Boyd H, Auffenberg T, Nakao S, Moldawer LL. Urinary cytokines for assessing inflammation in HIV-associated wasting. Cytokine 2001;13:305-13. [PMID: 11243709 DOI: 10.1006/cyto.2000.0830] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
405 Krunkosky TM, Maruo K, Potempa J, Jarrett CL, Travis J. Inhibition of tumor necrosis factor-alpha-induced RANTES secretion by alkaline protease in A549 cells. Am J Respir Cell Mol Biol 2005;33:483-9. [PMID: 16037484 DOI: 10.1165/rcmb.2005-0069OC] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
406 Essien BE, Kotiw M. Anti-inflammatory activity of hyperimmune plasma in a lipopolysaccharide-mediated rat air pouch model of inflammation. Inflammation 2012;35:58-64. [PMID: 21213030 DOI: 10.1007/s10753-010-9289-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
407 Jirillo E, Covelli V, Maffone AB, Greco B, Pece S, Fumarola D, Antonaci S, Simone C. Endotoxins, Cytokines, and Neuroimmune Networks with Special Reference to HIV Infection. Ann NY Acad Sci 1994;741:174-84. [DOI: 10.1111/j.1749-6632.1994.tb39657.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
408 Hise M, Compher C, Brown J. Inflammatory Mediators and Home Parenteral Nutrition. Nutr Clin Pract 2008;23:42-8. [DOI: 10.1177/011542650802300142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
409 Hsu SP, Wu MS, Yang CC, Huang KC, Liou SY, Hsu SM, Chien CT. Chronic green tea extract supplementation reduces hemodialysis-enhanced production of hydrogen peroxide and hypochlorous acid, atherosclerotic factors, and proinflammatory cytokines. Am J Clin Nutr 2007;86:1539-47. [PMID: 17991670 DOI: 10.1093/ajcn/86.5.1539] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 4.5] [Reference Citation Analysis]
410 Diaz-Castro J, Pulido-Moran M, Moreno-Fernandez J, Kajarabille N, de Paco C, Garrido-Sanchez M, Prados S, Ochoa JJ. Gender specific differences in oxidative stress and inflammatory signaling in healthy term neonates and their mothers. Pediatr Res 2016;80:595-601. [PMID: 27331351 DOI: 10.1038/pr.2016.112] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
411 Papadaki HA, Coulocheri S, Eliopoulos GD. Patients with chronic idiopathic neutropenia of adults have increased serum concentrations of inflammatory cytokines and chemokines. Am J Hematol 2000;65:271-7. [DOI: 10.1002/1096-8652(200012)65:4<271::aid-ajh1>3.0.co;2-r] [Cited by in Crossref: 30] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
412 Liu T, Qian WJ, Gritsenko MA, Xiao W, Moldawer LL, Kaushal A, Monroe ME, Varnum SM, Moore RJ, Purvine SO, Maier RV, Davis RW, Tompkins RG, Camp DG 2nd, Smith RD; Inflammation and the Host Response to Injury Large Scale Collaborative Research Programm. High dynamic range characterization of the trauma patient plasma proteome. Mol Cell Proteomics 2006;5:1899-913. [PMID: 16684767 DOI: 10.1074/mcp.M600068-MCP200] [Cited by in Crossref: 125] [Cited by in F6Publishing: 71] [Article Influence: 7.8] [Reference Citation Analysis]
413 Marie C, Losser MR, Fitting C, Kermarrec N, Payen D, Cavaillon JM. Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients. Am J Respir Crit Care Med 1997;156:1515-22. [PMID: 9372669 DOI: 10.1164/ajrccm.156.5.9702108] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 1.7] [Reference Citation Analysis]
414 Liem LM, van Lopik T, van Nieuwenhuijze AE, van Houwelingen HC, Aarden L, Goulmy E. Soluble Fas Levels in Sera of Bone Marrow Transplantation Recipients Are Increased During Acute Graft-Versus-Host Disease But Not During Infections. Blood 1998;91:1464-8. [DOI: 10.1182/blood.v91.4.1464] [Cited by in Crossref: 35] [Article Influence: 1.5] [Reference Citation Analysis]
415 Kern WV, Engel A, Schieffer S, Prümmer O, Kern P. Circulating tumor necrosis factor alpha (TNF), soluble TNF receptors, and interleukin-6 in human subacute bacterial endocarditis. Infect Immun 1993;61:5413-6. [DOI: 10.1128/iai.61.12.5413-5416.1993] [Cited by in Crossref: 29] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
416 Frieling JTM, van Deuren M, Wijdenes J, van Dalen R, Bartelink AKM, van der Linden CJ, Sauerwein RW. Interleukin-6 and its soluble receptor during acute meningococcal infections: Effect of plasma or whole blood exchange. Critical Care Medicine 1996;24:1801-5. [DOI: 10.1097/00003246-199611000-00007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
417 Chaturvedi M, Lapushin R, Aggarwal B. Tumor necrosis factor and lymphotoxin. Qualitative and quantitative differences in the mediation of early and late cellular response. Journal of Biological Chemistry 1994;269:14575-83. [DOI: 10.1016/s0021-9258(17)36662-0] [Cited by in Crossref: 66] [Article Influence: 2.4] [Reference Citation Analysis]
418 LaBue M, Colburn KK, Green LM. Thyrocytes isolated from autoimmune-diseased thyroids secrete soluble tumor necrosis factor-R1 that is related to their elevated protein kinase C activity. Thyroid 2004;14:249-62. [PMID: 15142358 DOI: 10.1089/105072504323030906] [Reference Citation Analysis]
419 Ochoa JJ, Díaz-Castro J, Kajarabille N, García C, Guisado IM, De Teresa C, Guisado R. Melatonin supplementation ameliorates oxidative stress and inflammatory signaling induced by strenuous exercise in adult human males. J Pineal Res. 2011;51:373-380. [PMID: 21615492 DOI: 10.1111/j.1600-079x.2011.00899.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
420 Wang P, Wood TJ, Zhou M, &NA; ZF, Chaudry IH. Inhibition of the Biologic Activity of Tumor Necrosis Factor Maintains Vascular Endothelial Cell Function during Hyperdynamic Sepsis: . The Journal of Trauma: Injury, Infection, and Critical Care 1996;40:694-701. [DOI: 10.1097/00005373-199605000-00003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
421 Bharucha AE, Jorgensen R, Lichtman SN, LaRusso NF, Lindor KD. A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis. Am J Gastroenterol. 2000;95:2338-2342. [PMID: 11007239 DOI: 10.1111/j.1572-0241.2000.02324.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 45] [Article Influence: 3.0] [Reference Citation Analysis]
422 Rathore VB, Advani SH, Nadkarni JJ. Altered Release of Tumor Necrosis Factor and Its Soluble Receptor in Non-Hodgkin's Lymphoma Patients. Cancer Detect Prev 1999;23:226-31. [DOI: 10.1046/j.1525-1500.1999.99024.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
423 Francés R, Chiva M, Sánchez E, González-Navajas JM, Llovet T, Zapater P, Soriano G, Muñoz C, Balanzó J, Pérez-Mateo M, Song XY, Guarner C, Such J. Bacterial translocation is downregulated by anti-TNF-alpha monoclonal antibody administration in rats with cirrhosis and ascites. J Hepatol 2007;46:797-803. [PMID: 17321632 DOI: 10.1016/j.jhep.2006.11.018] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
424 Windsor ACJ, Klava A, Somers SS, Guillou PJ, Reynolds JV. Manipulation of local and systemic host defence in the prevention of perioperative sepsis. British Journal of Surgery 1995;82:1460-7. [DOI: 10.1002/bjs.1800821106] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
425 Bradham CA, Plümpe J, Manns MP, Brenner DA, Trautwein C. Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am J Physiol 1998;275:G387-92. [PMID: 9724248 DOI: 10.1152/ajpgi.1998.275.3.G387] [Cited by in Crossref: 48] [Cited by in F6Publishing: 75] [Article Influence: 2.0] [Reference Citation Analysis]
426 Andersen J, Heilmann C, Jacobsen N, Nielsen C, Bendtzen K, Müller K. Differential effect of conditioning regimens on cytokine responses during allogeneic stem cell transplantation. Bone Marrow Transplant 2006;37:635-40. [PMID: 16474409 DOI: 10.1038/sj.bmt.1705295] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
427 Lyons PD, Benveniste EN. Cleavage of membrane-associated ICAM-1 from astrocytes: Involvement of a metalloprotease. Glia 1998;22:103-12. [DOI: 10.1002/(sici)1098-1136(199802)22:2<103::aid-glia1>3.0.co;2-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
428 Beishuizen A, Vermes I, Haanen C. Endogenous mediators in sepsis and septic shock. Adv Clin Chem 1998;33:55-131. [PMID: 10086175 DOI: 10.1016/s0065-2423(08)60206-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
429 Moosmayer D, Wajant H, Gerlach E, Schmidt M, Brocks B, Pfizenmaier K. Characterization of Different Soluble TNF Receptor (TNFR80) Derivatives: Positive Influence of the Intracellular Domain on Receptor/Ligand Interaction and TNF Neutralization Capacity. Journal of Interferon & Cytokine Research 1996;16:471-7. [DOI: 10.1089/jir.1996.16.471] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
430 Gerhauser I, Hansmann F, Puff C, Kumnok J, Schaudien D, Wewetzer K, Baumgärtner W. Theiler's murine encephalomyelitis virus induced phenotype switch of microglia in vitro. J Neuroimmunol 2012;252:49-55. [PMID: 22967352 DOI: 10.1016/j.jneuroim.2012.07.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
431 Menges T, Engel J, Welters I, Wagner RM, Little S, Ruwoldt R, Wollbrueck M, Hempelmann G. Changes in blood lymphocyte populations after multiple trauma: association with posttraumatic complications. Crit Care Med. 1999;27:733-740. [PMID: 10321662 DOI: 10.1097/00003246-199904000-00026] [Cited by in Crossref: 123] [Cited by in F6Publishing: 123] [Article Influence: 5.3] [Reference Citation Analysis]
432 Boontham P, Chandran P, Rowlands B, Eremin O. Surgical sepsis: dysregulation of immune function and therapeutic implications. The Surgeon 2003;1:187-206. [DOI: 10.1016/s1479-666x(03)80018-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
433 Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol 1998;274:R577-95. [PMID: 9530222 DOI: 10.1152/ajpregu.1998.274.3.R577] [Cited by in Crossref: 127] [Cited by in F6Publishing: 134] [Article Influence: 5.3] [Reference Citation Analysis]
434 Soong CV, Halliday MI, Barclay GR, Hood JM, Rowlands BJ, Barros D'Sa AA. Intramucosal acidosis and systemic host responses in abdominal aortic aneurysm surgery. Crit Care Med. 1997;25:1472-1479. [PMID: 9295820 DOI: 10.1097/00003246-199709000-00013] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 1.6] [Reference Citation Analysis]
435 Trudinger B, Wang J, Athayde N, Beutler L, Wang X. Association of Umbilical Placental Vascular Disease With Fetal Acute Inflammatory Cytokine Responses. Journal of the Society for Gynecologic Investigation 2016;9:152-7. [DOI: 10.1177/107155760200900306] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
436 Wiessner WH, Casey LC, Zbilut JP. Treatment of sepsis and septic shock: A review. Heart & Lung 1995;24:380-92. [DOI: 10.1016/s0147-9563(05)80059-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
437 Rose-John S, Heinrich PC. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 1994;300 ( Pt 2):281-90. [PMID: 8002928 DOI: 10.1042/bj3000281] [Cited by in Crossref: 547] [Cited by in F6Publishing: 538] [Article Influence: 19.5] [Reference Citation Analysis]
438 Finck BN, Johnson RW. Tumor necrosis factor-alpha regulates secretion of the adipocyte-derived cytokine, leptin. Microsc Res Tech. 2000;50:209-215. [PMID: 10891886 DOI: 10.1002/1097-0029(20000801)50:3%3C209::AID-JEMT4%3E3.0.CO;2-T] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
439 Döcke WD, Syrbe U, Meinecke A, Platzer C, Makki A, Asadullah K, Klug C, Zuckermann H, Reinke P, Brunner H, von Baehr R, Volk HD. Improvement of Monocyte Function — A New Therapeutic Approach? In: Reinhart K, Eyrich K, Sprung C, editors. Sepsis. Berlin: Springer Berlin Heidelberg; 1994. pp. 473-500. [DOI: 10.1007/978-3-642-85036-3_38] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
440 Borrelli E, Roux-lombard P, Grau GE, Girardin E, Ricou B, Dayer J, Suter PM. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk: . Critical Care Medicine 1996;24:392-7. [DOI: 10.1097/00003246-199603000-00006] [Cited by in Crossref: 190] [Cited by in F6Publishing: 176] [Article Influence: 7.3] [Reference Citation Analysis]
441 Wang YF, Wu XN, Wu Q, Zhang XQ, Chen XF, Zhou XH, Wen WQ, Chen MY. Biological significance of serum soluble tumor necrosis factor receptor I in hepatoma patients. World J Gastroenterol 1996; 2(2): 89-91 [DOI: 10.3748/wjg.v2.i2.89] [Cited by in CrossRef: 1] [Article Influence: 0.0] [Reference Citation Analysis]
442 Jean-Baptiste E. Cellular mechanisms in sepsis. J Intensive Care Med 2007;22:63-72. [PMID: 17456726 DOI: 10.1177/0885066606297123] [Cited by in Crossref: 100] [Cited by in F6Publishing: 98] [Article Influence: 6.7] [Reference Citation Analysis]
443 Martel CA, Mamedova LK, Minton JE, Jones ML, Carroll JA, Bradford BJ. Continuous low-dose infusion of tumor necrosis factor alpha in adipose tissue elevates adipose tissue interleukin 10 abundance and fails to alter metabolism in lactating dairy cows. Journal of Dairy Science 2014;97:4897-906. [DOI: 10.3168/jds.2013-7777] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
444 Moshyedi AK, Josephs MD, Abdalla EK, Mackay SLD, Edwards CK, Copeland EM, Moldawer LL. Increased Leptin Expression in Mice with Bacterial Peritonitis is Partially Regulated by Tumor Necrosis Factor Alpha. Infect Immun 1998;66:1800-2. [DOI: 10.1128/iai.66.4.1800-1802.1998] [Cited by in Crossref: 52] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
445 Chang HR, Dulloo AG, Bistrian BR. Role of cytokines in AIDS wasting. Nutrition 1998;14:853-63. [PMID: 9834928 DOI: 10.1016/s0899-9007(98)00108-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
446 Schäffer M, Barbul A. Lymphocyte function in wound healing and following injury. Br J Surg 1998;85:444-60. [PMID: 9607524 DOI: 10.1046/j.1365-2168.1998.00734.x] [Cited by in Crossref: 130] [Cited by in F6Publishing: 124] [Article Influence: 5.4] [Reference Citation Analysis]
447 Bemelmans MH, Greve JW, Gouma DJ, Buurman WA. Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality. Gut. 1996;38:447-453. [PMID: 8675101 DOI: 10.1136/gut.38.3.447] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 1.1] [Reference Citation Analysis]
448 Rider LG, Nistala K. The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes. J Intern Med 2016;280:24-38. [PMID: 27028907 DOI: 10.1111/joim.12444] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 13.5] [Reference Citation Analysis]
449 Hamnvik OR, Liu X, Petrou M, Gong H, Chamberland JP, Kim EH, Christophi CA, Kales SN, Christiani DC, Mantzoros CS. Soluble leptin receptor and leptin are associated with baseline adiposity and metabolic risk factors, and predict adiposity, metabolic syndrome, and glucose levels at 2-year follow-up: the Cyprus Metabolism Prospective Cohort Study. Metabolism 2011;60:987-93. [DOI: 10.1016/j.metabol.2010.09.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
450 Neirynck N, Glorieux G, Schepers E, Verbeke F, Vanholder R. Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease: a prospective cohort study. PLoS One 2015;10:e0122073. [PMID: 25823004 DOI: 10.1371/journal.pone.0122073] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.7] [Reference Citation Analysis]
451 Torre-amione G, Vooletich MT, Farmer JA. Role of Tumour Necrosis Factor-?? in the Progression of Heart Failure: Therapeutic Implications. Drugs 2000;59:745-51. [DOI: 10.2165/00003495-200059040-00002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
452 Kalinkovich A, Geleziunas R, Kemper O, Belenki D, Wallach D, Wainberg MA, Bentwich Z. Increased soluble tumor necrosis factor receptor expression and release by human immunodeficiency virus type 1 infection. J Interferon Cytokine Res 1995;15:749-57. [PMID: 8536102 DOI: 10.1089/jir.1995.15.749] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
453 Liu Z, Barber C, Wan L, Liu S, Hui MM, Furenlid LR, Xu H, Woolfenden JM. SPECT imaging of inflammatory response in ischemic-reperfused rat hearts using a 99mTc-labeled dual-domain cytokine ligand. J Nucl Med 2013;54:2139-45. [PMID: 24179185 DOI: 10.2967/jnumed.113.123497] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
454 Sabatine MS, Laufer T, Glimcher LH, Widmer M, Winn H, Auchincloss H. DELAYED REJECTION OF SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR-SECRETING TUMOR ALLOGRAFTS1: . Transplantation 1998;65:113-20. [DOI: 10.1097/00007890-199801150-00022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
455 Verwoerd A, Hijdra D, Vorselaars AD, Crommelin HA, van Moorsel CH, Grutters JC, Claessen AM. Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis. Clin Exp Immunol 2016;185:263-70. [PMID: 27158798 DOI: 10.1111/cei.12808] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
456 Oldenburg HSA, Rogy MA, Lazarus DD, van Zee KJ, Keeler BP, Chizzonite RA, Lowry SF, Moldawer LL. Cachexia and the acute-phase protein response in inflammation are regulated by interleukin-6. Eur J Immunol 1993;23:1889-94. [DOI: 10.1002/eji.1830230824] [Cited by in Crossref: 116] [Cited by in F6Publishing: 102] [Article Influence: 4.0] [Reference Citation Analysis]
457 Bry K, Lappalainen U, Hallman M. Cytokines and production of surfactant components. Seminars in Perinatology 1996;20:194-205. [DOI: 10.1016/s0146-0005(96)80048-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
458 Palomo M, Diaz-ricart M, Carbo C, Rovira M, Fernandez-aviles F, Martine C, Ghita G, Escolar G, Carreras E. Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: Role of the Conditioning Regimen and the Type of Transplantation. Biology of Blood and Marrow Transplantation 2010;16:985-93. [DOI: 10.1016/j.bbmt.2010.02.008] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 5.9] [Reference Citation Analysis]
459 Sileghem M, Flynn JN, Logan-Henfrey L, Ellis J. Tumour necrosis factor production by monocytes from cattle infected with Trypanosoma (Duttonella) vivax and Trypanosoma (Nannomonas) congolense: possible association with severity of anaemia associated with the disease. Parasite Immunol 1994;16:51-4. [PMID: 7908735 DOI: 10.1111/j.1365-3024.1994.tb00304.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 1.5] [Reference Citation Analysis]
460 de Gonzalo-calvo D, de Luxán-delgado B, Martínez-camblor P, Rodríguez-gonzález S, García-macia M, Suárez FM, Solano JJ, Rodríguez-colunga MJ, Coto-montes A. Chronic inflammation as predictor of 1-year hospitalization and mortality in elderly population: CHRONIC INFLAMMATION AS PREDICTOR OF 1-YEAR HOSPITALIZATION AND MORTALITY. European Journal of Clinical Investigation 2012;42:1037-46. [DOI: 10.1111/j.1365-2362.2012.02689.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
461 Smids C, Horjus Talabur Horje CS, Nierkens S, Drylewicz J, Groenen MJM, Wahab PJ, van Lochem EG. Candidate Serum Markers in Early Crohn's Disease: Predictors of Disease Course. J Crohns Colitis 2017;11:1090-100. [PMID: 28369318 DOI: 10.1093/ecco-jcc/jjx049] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
462 Murakami T, Iwagaki H, Saito S, Ohtani S, Kuroki K, Kuinose M, Tanaka N, Tanemoto K. Equivalence of the Acute Cytokine Surge and Myocardial Injury after Coronary Artery Bypass Grafting with and without a Novel Extracorporeal Circulation System. J Int Med Res 2005;33:133-49. [DOI: 10.1177/147323000503300201] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
463 Halin J. Treatment of rheumatoid arthritis: etanercept a recent advance. J Am Acad Nurse Pract 2000;12:433-41; quiz 442-4. [PMID: 11930442 DOI: 10.1111/j.1745-7599.2000.tb00149.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
464 Crown AL, Cottle K, Lightman SL, Falk S, Mohamed-ali V, Armstrong L, Millar AB, Holly JMP. What is the role of the insulin-like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated?: The insulin-like growth factor system in cancer cachexia. Clinical Endocrinology 2002;56:723-33. [DOI: 10.1046/j.1365-2265.2002.01540.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
465 de Pablo R, Monserrat J, Reyes E, Diaz-martin D, Rodriguez Zapata M, Carballo F, de la Hera A, Prieto A, Alvarez-mon M. Mortality in Patients With Septic Shock Correlates With Anti-Inflammatory But not Proinflammatory Immunomodulatory Molecules. J Intensive Care Med 2011;26:125-32. [DOI: 10.1177/0885066610384465] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
466 Romero R, Chaiworapongsa T, Espinoza J, Gomez R, Yoon BH, Edwin S, Mazor M, Maymon E, Berry S. Fetal plasma MMP-9 concentrations are elevated in preterm premature rupture of the membranes. Am J Obstet Gynecol 2002;187:1125-30. [PMID: 12439489 DOI: 10.1067/mob.2002.127312] [Cited by in Crossref: 82] [Cited by in F6Publishing: 81] [Article Influence: 4.1] [Reference Citation Analysis]
467 Doerschug K, Sanlioglu S, Flaherty DM, Wilson RL, Yarovinsky T, Monick MM, Engelhardt JF, Hunninghake GW. First-Generation Adenovirus Vectors Shorten Survival Time in a Murine Model of Sepsis. J Immunol 2002;169:6539-45. [DOI: 10.4049/jimmunol.169.11.6539] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
468 Chapman MJ. Adult Respiratory Distress Syndrome—An Update. Anaesth Intensive Care 1994;22:255-66. [DOI: 10.1177/0310057x9402200302] [Cited by in Crossref: 9] [Article Influence: 3.0] [Reference Citation Analysis]
469 Yano S, Umeda D, Maeda N, Fujimura Y, Yamada K, Tachibana H. Dietary Apigenin Suppresses IgE and Inflammatory Cytokines Production in C57BL/6N Mice. J Agric Food Chem 2006;54:5203-7. [DOI: 10.1021/jf0607361] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
470 García-Compeán D, Jáquez-Quintana JO, Lavalle-González FJ, González-González JA, Maldonado-Garza HJ, Villarreal-Pérez JZ. Plasma cytokine levels imbalance in cirrhotic patients with impaired glucose tolerance and diabetes mellitus. A prospective study. Ann Hepatol 2014;13:403-10. [PMID: 24927611 [PMID: 24927611 DOI: 10.1016/s1665-2681(19)30847-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
471 Torre-Amione G, Stetson SS, Farmer JA. Clinical implications of tumour necrosis factor alpha antagonism in patients with congestive heart failure. Ann Rheum Dis 1999;58 Suppl 1:I103-6. [PMID: 10577985 DOI: 10.1136/ard.58.2008.i103] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
472 An H, Chandra V, Piraino B, Borges L, Geczy C, Mcneil HP, Bryant K, Tedla N. Soluble LILRA3, a Potential Natural Antiinflammatory Protein, Is Increased in Patients with Rheumatoid Arthritis and Is Tightly Regulated by Interleukin 10, Tumor Necrosis Factor-α, and Interferon-γ. J Rheumatol 2010;37:1596-606. [DOI: 10.3899/jrheum.091119] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
473 Gordon AC, Lagan AL, Aganna E, Cheung L, Peters CJ, McDermott MF, Millo JL, Welsh KI, Holloway P, Hitman GA, Piper RD, Garrard CS, Hinds CJ. TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre study. Genes Immun 2004;5:631-40. [PMID: 15526005 DOI: 10.1038/sj.gene.6364136] [Cited by in Crossref: 73] [Cited by in F6Publishing: 62] [Article Influence: 4.3] [Reference Citation Analysis]
474 Schubert C, Haberkorn J, Ocaña-Peinado FM, König P, Sepp N, Schnapka-Köpf M, Fuchs D. Cause-effect relations between 55 kD soluble TNF receptor concentrations and specific and unspecific symptoms in a patient with mild SLE disease activity: an exploratory time series analysis study. BMC Res Notes 2015;8:465. [PMID: 26391351 DOI: 10.1186/s13104-015-1398-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
475 Lowry SF. Metabolic Responses to Anti-Cytokine Therapies. In: Wilmore DW, Carpentier YA, editors. Metabolic Support of the Critically Ill Patient. Berlin: Springer Berlin Heidelberg; 1993. pp. 333-46. [DOI: 10.1007/978-3-642-85011-0_19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
476 Shapira L, Soskolne WA, Houri Y, Barak V, Halabi A, Stabholz A. Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion. Infect Immun 1996;64:825-8. [PMID: 8641787 DOI: 10.1128/iai.64.3.825-828.1996] [Cited by in Crossref: 130] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
477 Macallan D, Sohal J, Walker C, Hill D, Moore M. Development of a Novel TNFα Ligand-Receptor Binding Assay for Screening Natchem TM Libraries. Journal of Receptors and Signal Transduction 2009;17:521-9. [DOI: 10.3109/10799899709036625] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
478 Pan X, Ye L, Liu Z, Wen H, Hu Y, Xu X. Effect of irrigation fluid temperature on core body temperature and inflammatory response during arthroscopic shoulder surgery. Arch Orthop Trauma Surg 2015;135:1131-9. [DOI: 10.1007/s00402-015-2246-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
479 Grassi-oliveira R, Brietzke E, Pezzi JC, Lopes RP, Teixeira AL, Bauer ME. Increased soluble tumor necrosis factor-α receptors in patients with major depressive disorder: Soluble TNF-α receptors in major depression. Psychiatry and Clinical Neurosciences 2009;63:202-8. [DOI: 10.1111/j.1440-1819.2008.01918.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 4.7] [Reference Citation Analysis]
480 Lowry SF, Calvano SE, van der Poll T. Measurement of Inflammatory Mediators in Clinical Sepsis. In: Vincent J, Sibbald WJ, editors. Clinical Trials for the Treatment of Sepsis. Berlin: Springer Berlin Heidelberg; 1995. pp. 86-105. [DOI: 10.1007/978-3-642-79224-3_6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
481 Leeuwenberg JFM, Froon AH, Vaessen LMB, Hoitsma AJ, Abramowicz D, Hooff J, Buurman WA. Soluble tumor necrosis factor-receptors are not a useful marker of acute allograft rejection: a study in patients with renal or cardiac allografts. Transplant Int 1995;8:459-65. [DOI: 10.1111/j.1432-2277.1995.tb01556.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
482 Bac DJ, Pruimboom WM, Mulder PGH, Zijlstra FJ, Wilson JHP. High interleukin-6 production within the peritoneal cavity in decompensated cirrhosis and malignancy-related ascites. Liver 1995;15:265-70. [DOI: 10.1111/j.1600-0676.1995.tb00683.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
483 Ernandez T, Mayadas TN. Immunoregulatory role of TNFalpha in inflammatory kidney diseases. Kidney Int. 2009;76:262-276. [PMID: 19436333 DOI: 10.1038/ki.2009.142] [Cited by in Crossref: 96] [Cited by in F6Publishing: 93] [Article Influence: 7.4] [Reference Citation Analysis]
484 Clayette P, Le Grand R, Noack O, Vaslin B, Le Naour R, Benveniste O, Théodoro F, Frétier P, Dormont D. Tumor necrosis factor-alpha in serum of macaques during SIVmac251 acute infection. J Med Primatol 1995;24:94-100. [PMID: 8613979 DOI: 10.1111/j.1600-0684.1995.tb00152.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
485 Gómez-Banoy N, Cuevas V, Higuita A, Aranzález LH, Mockus I. Soluble tumor necrosis factor receptor 1 is associated with diminished estimated glomerular filtration rate in colombian patients with type 2 diabetes. J Diabetes Complications 2016;30:852-7. [PMID: 27068267 DOI: 10.1016/j.jdiacomp.2016.03.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
486 Arnalich F, Martinez P, Hernanz A, González J, Plaza MA, Montiel C, Peña JM, Vázquez JJ. Altered concentrations of appetite regulators may contribute to the development and maintenance of HIV-associated wasting: . AIDS 1997;11:1129-34. [DOI: 10.1097/00002030-199709000-00008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
487 Macqueen HA, Sadler D, Mattacks C. Dietary fatty acids influence the appearance of tumour necrosis factor-α receptors on adipocytes following an immune challenge. Br J Nutr 2000;84:387-92. [DOI: 10.1017/s0007114500001677] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
488 Cadranel J, Philippe C, Philippe B, Milleron B, Fouqueray B, Mayaud C, Baud L. Increased expression and occupancy of receptors for tumour necrosis factor on blood monocytes from tuberculosis patients. Clin Exp Immunol 1993;94:51-6. [PMID: 8403517 DOI: 10.1111/j.1365-2249.1993.tb05976.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
489 Rao S, Liu X, Freedman BD, Behrens EM. Spleen tyrosine kinase (Syk)-dependent calcium signals mediate efficient CpG-induced exocytosis of tumor necrosis factor α (TNFα) in innate immune cells. J Biol Chem. 2013;288:12448-12458. [PMID: 23515313 DOI: 10.1074/jbc.m113.454405] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
490 Bilello JA, Tennant FS. Patterns of chronic inflammation in extensively treated patients with arachnoiditis and chronic intractable pain. Postgrad Med 2017;129:87-91. [PMID: 27929717 DOI: 10.1080/00325481.2017.1270155] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
491 Noguchi M, Hiwatashi N, Liu Z, Toyota T. Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease. Gut 1998;43:203-9. [PMID: 10189845 DOI: 10.1136/gut.43.2.203] [Cited by in Crossref: 76] [Cited by in F6Publishing: 74] [Article Influence: 3.3] [Reference Citation Analysis]
492 Schell SR, Wessels FJ, Abouhamze A, Moldawer LL, Copeland EM 3rd. Pro- and antiinflammatory cytokine production after radiofrequency ablation of unresectable hepatic tumors. J Am Coll Surg 2002;195:774-81. [PMID: 12495309 DOI: 10.1016/s1072-7515(02)01333-9] [Cited by in Crossref: 38] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
493 Neuman MG. Apoptosis in diseases of the liver. Crit Rev Clin Lab Sci. 2001;38:109-166. [PMID: 11347718 DOI: 10.1080/20014091084182] [Cited by in Crossref: 88] [Cited by in F6Publishing: 81] [Article Influence: 4.2] [Reference Citation Analysis]
494 Riccioli A, Starace D, D’alessio A, Starace G, Padula F, De Cesaris P, Filippini A, Ziparo E. TNF-α and IFN-γ Regulate Expression and Function of the Fas System in the Seminiferous Epithelium. J Immunol 2000;165:743-9. [DOI: 10.4049/jimmunol.165.2.743] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 3.2] [Reference Citation Analysis]
495 Granado M, Martín AI, López-menduiña M, López-calderón A, Villanúa MA. GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia. American Journal of Physiology-Endocrinology and Metabolism 2008;294:E131-41. [DOI: 10.1152/ajpendo.00308.2007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
496 Sileghem M, Flynn JN, Darji A, De Baetselier P, Naessens J. African Trypanosomiasis. Parasitic Infections and the Immune System. Elsevier; 1994. pp. 1-51. [DOI: 10.1016/b978-0-08-092405-2.50005-9] [Cited by in Crossref: 16] [Article Influence: 0.6] [Reference Citation Analysis]
497 Tokushige K, Yamaguchi N, Ikeda I, Hashimoto E, Yamauchi K, Hayashi N. Significance of soluble TNF receptor-I in acute-type fulminant hepatitis. Am J Gastroenterology 2000;95:2040-6. [DOI: 10.1111/j.1572-0241.2000.02270.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
498 De Kossodo S, Critico B, Grau GE. Modulation of the transcripts for tumor necrosis factor-α and its receptorsin vivo. Eur J Immunol 1994;24:769-72. [DOI: 10.1002/eji.1830240342] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
499 Ossege LM, Sindern E, Voss B, Malin J. Expression of TNFα and TGFβ1 in Guillain-Barré syndrome: correlation of a low TNFα-/TGFβ1-mRNA ratio with good recovery and signs for immunoregulation within the cerebrospinal fluid compartment: TNFα and TGFβ1 in Guillain-Barré syndrome. European Journal of Neurology 2000;7:17-25. [DOI: 10.1046/j.1468-1331.2000.00005.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
500 Nagaki M, Moriwaki H. Implication of cytokines: Roles of tumor necrosis factor-alpha in liver injury. Hepatol Res 2008;38 Suppl 1:S19-28. [PMID: 19125946 DOI: 10.1111/j.1872-034X.2008.00422.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
501 Courtney JM, Matata BM, Yin HQ, Esposito A, Mahiout A, Taggart DP, Lowe G. The influence of biomaterials on inflammatory responses to cardiopulmonary bypass. Perfusion 1996;11:220-8. [DOI: 10.1177/026765919601100307] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
502 Secor VH. The Inflammatory/Immune Response in Critical Illness: Role of the Systemic Inflammatory Response Syndrome. Critical Care Nursing Clinics of North America 1994;6:251-64. [DOI: 10.1016/s0899-5885(18)30490-8] [Cited by in Crossref: 10] [Article Influence: 0.4] [Reference Citation Analysis]
503 Matuska A, O'shaughnessey K, King W, Woodell-May J. Autologous solution protects bovine cartilage explants from IL-1α- and TNFα-induced cartilage degradation. J Orthop Res 2013;31:1929-35. [PMID: 23966313 DOI: 10.1002/jor.22464] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
504 Ma X. TNF-α and IL-12:a balancing act in macrophage functioning. Microbes and Infection 2001;3:121-9. [DOI: 10.1016/s1286-4579(00)01359-9] [Cited by in Crossref: 87] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
505 Ho GY, Xue X, Cushman M, McKeown-Eyssen G, Sandler RS, Ahnen DJ, Barry EL, Saibil F, Bresalier RS, Rohan TE, Baron JA. Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas. J Natl Cancer Inst 2009;101:1650-4. [PMID: 19822838 DOI: 10.1093/jnci/djp346] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
506 Bao L, Lindgren J, Zhu Y, Ljunggren H, Zhu J. Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis. Neurobiology of Disease 2003;12:73-81. [DOI: 10.1016/s0969-9961(02)00007-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
507 Santolaya JL, Kugler L, Francois L, Stefano VD, Ebert GA, Wolf R, Wang B, Santolaya-Forgas J. Baseline TNFα operational capacity in fetal and maternal circulation prior to the onset of labor: "tuned for different purposes". Reprod Sci 2013;20:838-44. [PMID: 23287097 DOI: 10.1177/1933719112468953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
508 Sacco S, Heremans H, Echtenacher B, Buurman WA, Amraoui Z, Goldman M, Ghezzi P. Protective Effect of a Single Interleukin-12 (IL-12) Predose Against the Toxicity of Subsequent Chronic IL-12 in Mice: Role of Cytokines and Glucocorticoids. Blood 1997;90:4473-9. [DOI: 10.1182/blood.v90.11.4473] [Cited by in Crossref: 23] [Article Influence: 0.9] [Reference Citation Analysis]
509 Rogy MA, Moldawer LL, Oldenburg HS, Thompson WA, Montegut WJ, Stackpole SA, Kumar A, Palladino MA, Marra MN, Lowry SF. Anti-endotoxin therapy in primate bacteremia with HA-1A and BPI. Ann Surg 1994;220:77-85. [PMID: 8024362 DOI: 10.1097/00000658-199407000-00011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
510 Braun N, Hoess C, Kutz A, Christ-Crain M, Thomann R, Henzen C, Zimmerli W, Mueller B, Schuetz P. Obesity paradox in patients with community-acquired pneumonia: Is inflammation the missing link? Nutrition 2017;33:304-10. [PMID: 27742103 DOI: 10.1016/j.nut.2016.07.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
511 Hurt N, Thein M, Smith T, Bordmann G, Gallati H, Drees N, Tanner M, Weiss N. Immunological markers of childhood fevers in an area of intense and perennial malaria transmission. Clin Exp Immunol 1995;100:59-66. [PMID: 7697924 DOI: 10.1111/j.1365-2249.1995.tb03604.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
512 Kallinowski B, Haseroth K, Marinos G, Hanck C, Stremmel W, Theilmann L, Singer MV, Rossol S. Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin Exp Immunol. 1998;111:269-277. [PMID: 9486392 DOI: 10.1046/j.1365-2249.1998.00469.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 3.3] [Reference Citation Analysis]
513 Amiot F, Fitting C, Tracey KJ, Cavaillon J, Dautry F. Lipopolysaccharide-Induced Cytokine Cascade and Lethality in LTα/TNFα-Deficient Mice. Mol Med 1997;3:864-75. [DOI: 10.1007/bf03401722] [Cited by in Crossref: 50] [Article Influence: 2.0] [Reference Citation Analysis]
514 Lozano JM, Collado JA, Medina T, Muntane J. Protection against liver injury by PGE1 or anti-TNF-alpha is associated with a reduction of TNF-R1 expression in hepatocytes. Scand J Gastroenterol. 2003;38:1169-1175. [PMID: 14686721 DOI: 10.1080/00365520310006063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
515 Moore RN, Munk ME, Anding P, Schettini APM, Cunha MDGS, Kaufmann SHE. Soluble Tumor Necrosis Factor Alpha Receptors in Sera from Leprosy Patients. Infect Immun 1999;67:423-5. [DOI: 10.1128/iai.67.1.423-425.1999] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]